The O O 0.9649931192398071
immunoprecipitation O O 0.4533434808254242
analysis O O 0.9763585329055786
of O O 0.9921784400939941
DER B-protein O 0.8607980012893677
demonstrated O O 0.9732062816619873
that O O 0.9922568798065186
Aos B-protein B-protein 0.37548771500587463
binds O O 0.9052315354347229
to O O 0.9918768405914307
DER O O 0.8626947999000549
in O O 0.9920434355735779
living O O 0.9797711968421936
DER/ B-cell O 0.6688438653945923
S2 I-cell O 0.5212442874908447
cells I-cell O 0.9702636003494263
( O O 0.9770033955574036
Fig O O 0.8929640650749207
. O O 0.9920706152915955
2A) O O 0.7550376653671265
. O O 0.9812752604484558

This O O 0.9792183041572571
interaction O O 0.9742310643196106
is O O 0.9914018511772156
mutually O O 0.9740025997161865
exclusive O O 0.9339545369148254
( O O 0.9743891954421997
Fig O O 0.8740056157112122
. O O 0.9900054335594177
1E O B-protein 0.4992567002773285
and O O 0.9893177151679993
F) O O 0.750477135181427
, O O 0.9904361367225647
suggesting O O 0.9778434634208679
that O O 0.9951639175415039
the O O 0.9923140406608582
binding O O 0.9731988310813904
of O O 0.99111008644104
SAF-A B-protein O 0.7303523421287537
and O O 0.9894604682922363
p300 B-protein O 0.5501917004585266
may O O 0.9894524812698364
be O O 0.9944005608558655
disrupted O O 0.953871488571167
in O O 0.9916608929634094
adenovirus-transformed B-cell O 0.7591507434844971
cell I-cell O 0.9590681791305542
lines I-cell O 0.9761282205581665
. O O 0.9836834073066711

SNAPs B-protein-family O 0.5047508478164673
act O O 0.9835895895957947
as O O 0.9917755126953125
adapters O O 0.8137665390968323
and O O 0.9932538866996765
are O O 0.9949082732200623
required O O 0.9898425936698914
for O O 0.993351399898529
binding O O 0.973412811756134
of O O 0.9913023710250854
NSF B-protein O 0.7254454493522644
to O O 0.9925946593284607
the O O 0.9915846586227417
7 B-protein-complex O 0.96507328748703
S I-protein-complex O 0.8828797936439514
complex I-protein-complex O 0.9739125967025757
. O O 0.9834664463996887

Under O O 0.9726245999336243
these O O 0.9945244789123535
conditions O O 0.9926043748855591
, O O 0.9876157641410828
Hbp B-protein B-protein 0.282060831785202
binds O O 0.89178866147995
heme B-chemical O 0.5233248472213745
in O O 0.989683985710144
a O O 0.9888796806335449
1 O O 0.9794048070907593
: O O 0.9847891330718994
1 O O 0.976711094379425
molar O O 0.8516163229942322
ratio O O 0.9640622138977051
( O O 0.9780630469322205
unpublished O O 0.93012934923172
data) O O 0.7486287951469421
. O O 0.9812460541725159

The O O 0.9694256782531738
cadherin-bound - O 0.7475566864013672
form O O 0.9842166900634766
of O O 0.9909073114395142
beta-catenin B-protein-family O 0.5702376961708069
is O O 0.9864131212234497
anchored O O 0.8969411253929138
at O O 0.9901036024093628
the O O 0.9911207556724548
plasma O O 0.8671219348907471
membrane O O 0.9216544032096863
( O O 0.9722617268562317
4) O O 0.7434920072555542
. O O 0.9807026982307434

 O O 0.4401032328605652
Finally O O 0.9541260004043579
, O O 0.9869542717933655
synapsin B-protein-family B-protein 0.25150156021118164
binds O O 0.9198505878448486
simultaneously O O 0.9692226052284241
to O O 0.9940804839134216
both O O 0.9913362264633179
actin B-protein-family O 0.8017966151237488
and O O 0.9909263849258423
synaptic B-organelle O 0.7670543789863586
vesicles I-organelle O 0.7059267163276672
( O O 0.967577338218689
Benfenati O O 0.75700843334198
et O O 0.9435946345329285
al O O 0.9729968905448914
. O O 0.9942833781242371
, O O 0.9922869205474854
1992) O O 0.761025071144104
. O O 0.9813993573188782

We O O 0.9778774380683899
show O O 0.9808453321456909
that O O 0.9927322268486023
Hsp70 B-protein B-protein 0.4210553765296936
binding O O 0.9708915948867798
is O O 0.989227294921875
regulated O O 0.9673916697502136
by O O 0.993567168712616
the O O 0.9912473559379578
phosphorylation O O 0.8903249502182007
state O O 0.9868819117546082
of O O 0.9928667545318604
the O O 0.9910157918930054
turn O O 0.9723064303398132
motif O O 0.8454525470733643
, O O 0.9909247159957886
one O O 0.9905283451080322
of O O 0.9936550855636597
the O O 0.9922435879707336
two O O 0.9906173348426819
conserved O O 0.8766050338745117
carboxyl-terminal O O 0.7043522596359253
phosphorylation O O 0.8753165006637573
sites O O 0.9736766815185547
, O O 0.9924840331077576
and O O 0.9941813349723816
that O O 0.9922686219215393
Hsp70 O B-protein 0.340841680765152
binds O O 0.8938632607460022
mature O O 0.933986485004425
PKC B-protein-family B-protein 0.4003881514072418
that O O 0.9938212037086487
has O O 0.9897732138633728
become O O 0.9792473912239075
dephosphorylated O O 0.5285965204238892
, O O 0.9896272420883179
rather O O 0.9904537200927734
than O O 0.9929525256156921
newly O O 0.9525998830795288
synthesized O O 0.8256524801254272
PKC O B-protein 0.3963790535926819
that O O 0.9940916895866394
has O O 0.9909934401512146
yet O O 0.989654004573822
to O O 0.994675874710083
be O O 0.9939478635787964
phosphorylated O O 0.77704918384552
. O O 0.9809266328811646

 O O 0.4705280065536499
All O O 0.9900627732276917
of O O 0.993402898311615
these O O 0.9938165545463562
residues O O 0.9381275177001953
, O O 0.9915676712989807
except O O 0.976402759552002
Ser45 O O 0.7616751790046692
, O O 0.9905256032943726
are O O 0.9942441582679749
located O O 0.9639819860458374
close O O 0.9817156195640564
to O O 0.9936855435371399
site O O 0.9656525254249573
of O O 0.9907666444778442
cofilin B-protein O 0.7181259989738464
implicated O O 0.9295588731765747
genetically O O 0.9698403477668762
in O O 0.9913062453269958
actin B-protein-family O 0.7928540110588074
binding O O 0.9696409106254578
, O O 0.9917112588882446
suggesting O O 0.9777010083198547
they O O 0.9947274327278137
also O O 0.9908536672592163
form O O 0.9876837134361267
part O O 0.9866516590118408
of O O 0.9933231472969055
the O O 0.9887079000473022
actin-binding O B-protein 0.4008013904094696
surface O O 0.9806068539619446
. O O 0.9822047352790833

TL B-protein B-protein 0.36941325664520264
directly O O 0.9734034538269043
binds O O 0.9039512276649475
to O O 0.9936000108718872
the O O 0.9896738529205322
CD8αα B-protein-complex O 0.6733090877532959
homodimer O O 0.5679450631141663
with O O 0.9904830455780029
a O O 0.9885247349739075
significantly O O 0.9798909425735474
stronger O O 0.9677042365074158
affinity O O 0.9248616695404053
than O O 0.9933964014053345
to O O 0.9944235682487488
the O O 0.9897281527519226
CD8αβ B-protein-complex O 0.6343190670013428
heterodimer O B-protein 0.41534456610679626
( O O 0.9498940110206604
Kd O B-protein 0.2693778872489929
∼10 O O 0.7616888284683228
μM O O 0.8410760164260864
versus O O 0.9319336414337158
100 O O 0.9685835838317871
μM) O O 0.7780467867851257
, O O 0.9910549521446228
an O O 0.9931079149246216
affinity O O 0.9220738410949707
that O O 0.9935508966445923
surpasses O O 0.8369811773300171
that O O 0.9938902854919434
of O O 0.990954577922821
MHCIa B-protein-family O 0.7219414710998535
molecules O O 0.9624143242835999
to O O 0.9937899708747864
either O O 0.9890945553779602
the O O 0.991006076335907
CD8αβ O O 0.7493166923522949
or O O 0.9881504774093628
CD8αα O O 0.6525294780731201
Leishman O B-protein 0.471638947725296
et O O 0.9279621243476868
al O O 0.9699594378471375
. O O 0.9938639402389526
2001 O O 0.9741858243942261
, O O 0.99208003282547
Moody O O 0.8536210060119629
et O O 0.9471296668052673
al O O 0.9734559655189514
. O O 0.9943095445632935
2001 O O 0.9735756516456604
. O O 0.9848959445953369

Furthermore O O 0.912168025970459
, O O 0.9903165698051453
G6P B-protein-family O 0.7742977738380432
binding O O 0.9710091352462769
to O O 0.9914733171463013
GS B-protein-family O 0.6243985891342163
induces O O 0.8580557703971863
a O O 0.9858266711235046
conformational O O 0.8892458081245422
change O O 0.9885780811309814
, O O 0.9925215840339661
increasing O O 0.9862613081932068
its O O 0.9909718036651611
susceptibility O O 0.9160721302032471
to O O 0.9913856983184814
dephosphorylation O O 0.6232272982597351
( O O 0.9721062183380127
5 O O 0.9767822623252869
, O O 0.9915457367897034
6) O O 0.7555224895477295
. O O 0.981177806854248

In O O 0.976493775844574
comparing O O 0.957726776599884
DNA B-DNA O 0.9652983546257019
binding O O 0.9739341735839844
of O O 0.9901512861251831
Dm B-drug B-protein 0.4902530312538147
and O O 0.9891775250434875
MGTs B-drug O 0.7407770156860352
, O O 0.9900006055831909
it O O 0.9934912323951721
should O O 0.9925063252449036
be O O 0.9948821067810059
noted O O 0.9848056435585022
that O O 0.9953336119651794
the O O 0.992063581943512
substitution O O 0.9346920847892761
of O O 0.9924066662788391
the O O 0.9862706661224365
amino-terminal O B-protein 0.32577911019325256
formyl O O 0.46203330159187317
and O O 0.9891074895858765
the O O 0.9888831973075867
carboxyl-terminal O O 0.695428729057312
amidine O O 0.7242862582206726
groups O O 0.9873314499855042
of O O 0.9902843832969666
Dm O O 0.5025073885917664
by O O 0.9885290265083313
acetamido O O 0.7402613759040833
and O O 0.990738570690155
-CH2CH2N+H(CH3)2 B-chemical O 0.755652904510498
groups O O 0.9881532788276672
, O O 0.9919953346252441
respectively O O 0.9711613059043884
, O O 0.9918925762176514
yields O O 0.9655101299285889
compound O O 0.9512642621994019
2 O O 0.9719839096069336
along O O 0.982658863067627
with O O 0.9932807087898254
a O O 0.9873031973838806
three-order O O 0.7655970454216003
of O O 0.9913737177848816
magnitude O O 0.9644616842269897
decrease O O 0.9781942963600159
in O O 0.9927034378051758
binding O O 0.971352756023407
affinity O O 0.9128334522247314
( O O 0.971175491809845
K1K2 O O 0.7623434066772461
) O O 0.9785223603248596
compared O O 0.9847838878631592
with O O 0.9917237162590027
Dm O O 0.48021605610847473
. O O 0.9777814745903015

The O O 0.9750725626945496
structure O O 0.9805896282196045
of O O 0.9937443137168884
the O O 0.9903855323791504
HP1 B-protein O 0.6940369009971619
chromodomain O O 0.7067552208900452
bound O O 0.9571978449821472
to O O 0.9910049438476562
histone B-protein-family O 0.6405134201049805
H3 I-protein-family O 0.6016035079956055
di- O O 0.7130711674690247
or O O 0.9892205595970154
trimethylated O O 0.7584183216094971
at O O 0.9860905408859253
lysine B-amino-acid O 0.7743220329284668
9 I-amino-acid O 0.9606122374534607
shows O O 0.9803867936134338
that O O 0.9947412014007568
either O O 0.9855089783668518
peptide O O 0.7840366363525391
fits O O 0.9130728244781494
in O O 0.991886556148529
a O O 0.9866064190864563
groove O O 0.7262840270996094
and O O 0.9911301136016846
lodges O O 0.8260161876678467
the O O 0.9890968799591064
methyllysine B-amino-acid O 0.7591173648834229
in O O 0.9912770986557007
a O O 0.9863954782485962
hydrophobic O O 0.8200958371162415
pocket O O 0.7922981381416321
( O O 0.9701517224311829
Nielsen O O 0.8417165875434875
et O O 0.9434304237365723
al O O 0.9708473086357117
. O O 0.9938511848449707
, O O 0.9931515455245972
2002 O O 0.9723026156425476
; O O 0.989629328250885
Jacobs O O 0.857230544090271
and O O 0.992408037185669
Khorasanizadeh O O 0.7795048356056213
, O O 0.9916483163833618
2002 O O 0.9731845855712891
) O O 0.9811562299728394
. O O 0.9852598905563354

Binding O O 0.9173709750175476
of O O 0.9858681559562683
U7 B-protein-RNA-complex B-protein 0.20503556728363037
snRNP I-protein-RNA-complex O 0.39273136854171753
to O O 0.9872746467590332
the O O 0.9884486794471741
pre-mRNA B-RNA O 0.6159929037094116
occurs O O 0.9811805486679077
by O O 0.9930545687675476
base O O 0.9700629711151123
pairing O O 0.9066139459609985
between O O 0.9924227595329285
the O O 0.9921948909759521
5 O O 0.9749016761779785
' O O 0.9720978736877441
end O O 0.9860111474990845
of O O 0.9855644106864929
U7 O O 0.18776652216911316
snRNA O B-protein 0.28980138897895813
and O O 0.9855239987373352
the O O 0.9860979318618774
HDE B-DNA B-protein 0.3062204420566559
( O O 0.9798228144645691
5 O O 0.9731796383857727
, O O 0.9918249249458313
48 O O 0.9562566876411438
) O O 0.9798259139060974
and O O 0.9942082166671753
is O O 0.9903228282928467
stabilized O O 0.8955952525138855
by O O 0.9929051995277405
interaction O O 0.972969114780426
of O O 0.9912940859794617
SLBP B-protein O 0.7372180223464966
bound O O 0.9590421319007874
to O O 0.9933114051818848
the O O 0.988923192024231
histone B-RNA O 0.649531900882721
pre-mRNA I-RNA O 0.590576708316803
with O O 0.9910316467285156
a O O 0.9886735081672668
component O O 0.951646625995636
of O O 0.9862513542175293
U7 O B-protein 0.20616358518600464
snRNP O O 0.43751928210258484
, O O 0.9865543842315674
most O O 0.993156373500824
likely O O 0.9874173402786255
hZFP100 B-protein O 0.7621793150901794
( O O 0.9714887142181396
9) O O 0.7462285161018372
. O O 0.981037437915802

Third O O 0.9362382888793945
, O O 0.9922114610671997
the O O 0.9927281141281128
preferential O O 0.9501726627349854
binding O O 0.973438024520874
of O O 0.9917265176773071
AEF-1 B-protein O 0.7659302949905396
to O O 0.9926488995552063
the O O 0.98997962474823
proximal O O 0.8157813549041748
Inr B-DNA O 0.547314465045929
further O O 0.9833819270133972
destabilizes O O 0.6839303970336914
interactions O O 0.9720619916915894
with O O 0.9938076138496399
the O O 0.9916132688522339
pre-initiation B-protein-complex O 0.7660384178161621
complex I-protein-complex O 0.9727243185043335
. O O 0.9833508133888245

Therefore O O 0.96162348985672
, O O 0.9923330545425415
we O O 0.9939420819282532
will O O 0.9931753277778625
consider O O 0.9846953749656677
the O O 0.9929370284080505
differences O O 0.989993155002594
between O O 0.9930481910705566
the O O 0.9893059134483337
GppNHp-bound - O 0.619327962398529
RalA B-protein B-protein 0.31540346145629883
structure O O 0.9728595614433289
complexed O O 0.5295103192329407
with O O 0.9891139268875122
Sec5 B-protein O 0.7713277339935303
and O O 0.9927910566329956
the O O 0.988956868648529
GDP-bound B-protein O 0.6359277367591858
RalA I-protein B-protein 0.3538423776626587
structure O O 0.9779044389724731
to O O 0.9932437539100647
be O O 0.9944414496421814
primarily O O 0.9847720265388489
caused O O 0.9856195449829102
by O O 0.9936745166778564
the O O 0.9919965863227844
difference O O 0.9754948616027832
in O O 0.9909394979476929
nucleotide O O 0.8392693400382996
state O O 0.9868789315223694
rather O O 0.9902974963188171
than O O 0.9935978651046753
caused O O 0.9863954782485962
by O O 0.9938202500343323
binding O O 0.9757869243621826
of O O 0.9919601082801819
Sec5 O O 0.7516034245491028
to O O 0.9885644316673279
RalA O B-protein 0.3372395634651184
. O O 0.9787458181381226

To O O 0.9751430749893188
assay O O 0.809790313243866
syntaxin B-protein-family O 0.7361558675765991
binding O O 0.9713360667228699
to O O 0.9938933253288269
the O O 0.9903924465179443
C2A B-protein-domain O 0.7217077016830444
domain I-protein-domain O 0.9082526564598083
of O O 0.9903154969215393
synaptotagmin B-protein-family O 0.7468492984771729
, O O 0.9898180365562439
1 O O 0.9749582409858704
mM O O 0.9498337507247925
CaCl2 B-chemical O 0.7625117301940918
was O O 0.9876382350921631
added O O 0.9839921593666077
to O O 0.9931555390357971
buffer O O 0.9100977778434753
B O O 0.8606576323509216
( O O 0.9725431799888611
buffer O O 0.9303494095802307
A O O 0.9883911609649658
containing O O 0.9677615165710449
0 O O 0.9463974833488464
. O O 0.9921637773513794
1% O O 0.7484936118125916
( O O 0.9634288549423218
w/v O B-protein 0.3609274923801422
) O O 0.9707504510879517
Triton - O 0.5579973459243774
X-100) - O 0.6932539939880371
. O O 0.9798882603645325

11 O O 0.936488926410675
Given O O 0.9885801672935486
this O O 0.9939822554588318
similarity O O 0.9632207751274109
in O O 0.9928480386734009
surface O O 0.9838601350784302
densities O O 0.9361543655395508
for O O 0.9931424856185913
the O O 0.9920108914375305
various O O 0.9882726073265076
myosins B-protein-family O 0.7472046613693237
, O O 0.9898618459701538
it O O 0.9929816722869873
appears O O 0.9692148566246033
that O O 0.9949414134025574
the O O 0.9919934272766113
binding O O 0.9720510244369507
of O O 0.9907323122024536
myosin B-protein-complex O 0.6421520709991455
to O O 0.9910168647766113
the O O 0.988403856754303
nitrocellulose B-reagent O 0.5965737700462341
surface O O 0.9797309041023254
is O O 0.991107165813446
independent O O 0.9786151647567749
of O O 0.9903200268745422
myosin O O 0.5166754722595215
isoform O O 0.5775732398033142
. O O 0.9773308038711548

Drosophila O O 0.46095705032348633
CBP B-protein O 0.48521658778190613
acetylates O O 0.6935461759567261
a O O 0.9846328496932983
conserved O O 0.9014924168586731
lysine O O 0.8132948875427246
in O O 0.9924722909927368
the O O 0.990820586681366
Armadillo-binding - O 0.7335728406906128
domain O O 0.9117826223373413
of O O 0.9897211194038391
Drosophila O O 0.7618907690048218
TCF B-protein-family O 0.5803765058517456
, O O 0.989081621170044
which O O 0.9919341802597046
lowers O O 0.815500795841217
the O O 0.9897016286849976
affinity O O 0.9154284000396729
of O O 0.9900227189064026
Armadillo O O 0.64167320728302
binding O O 0.9668047428131104
to O O 0.9918236136436462
dTCF B-protein-family O 0.7232981324195862
( O O 0.9634280800819397
Waltzer O B-protein 0.4298010766506195
and O O 0.9914085268974304
Bienz O O 0.768381655216217
, O O 0.9896169900894165
1998) O O 0.746703028678894
. O O 0.9809526801109314

The O O 0.9749061465263367
amount O O 0.9835749864578247
of O O 0.9914931654930115
S223F B-protein O 0.713485836982727
coat I-protein O 0.9014481902122498
protein I-protein O 0.9401354789733887
bound O O 0.9635723829269409
to O O 0.9923741221427917
GroEL B-protein O 0.7578496932983398
increased O O 0.9848917722702026
when O O 0.9903171062469482
the O O 0.9901981353759766
GroEL O O 0.7296385169029236
concentration O O 0.9492500424385071
was O O 0.987908661365509
raised O O 0.9762997031211853
regardless O O 0.9797505140304565
of O O 0.9928909540176392
temperature O O 0.9770748615264893
, O O 0.9919694066047668
suggesting O O 0.9775166511535645
that O O 0.9950266480445862
even O O 0.9920980930328369
at O O 0.9907748103141785
low O O 0.9807156324386597
temperatures O O 0.978394627571106
the O O 0.9917545318603516
improper O O 0.9579210877418518
folding O O 0.872039258480072
of O O 0.9896635413169861
S223F O O 0.6993091106414795
coat O O 0.8996304869651794
protein O O 0.9404737949371338
exceeded O O 0.9562835097312927
the O O 0.9921039342880249
capacity O O 0.9815055727958679
of O O 0.9921132326126099
GroEL O O 0.769526481628418
to O O 0.9925609230995178
accommodate O O 0.9557908177375793
substrates O O 0.9426567554473877
. O O 0.9828973412513733

A O O 0.9597350358963013
densitometric O O 0.7679587006568909
analysis O O 0.9824490547180176
of O O 0.9933607578277588
the O O 0.98797208070755
Coomassie - B-protein 0.3471960127353668
Blue-stained - O 0.7543783187866211
proteins O O 0.953830361366272
indicated O O 0.9775291681289673
that O O 0.9951663017272949
the O O 0.9907734394073486
beta1D B-experimental-construct O 0.730672299861908
construct O O 0.9373288750648499
bound O O 0.9609807133674622
9 O O 0.9652832746505737
times O O 0.985893726348877
more O O 0.9925897121429443
talin B-protein-family B-protein 0.4897991120815277
, O O 0.9904650449752808
and O O 0.9938768744468689
the O O 0.9904143214225769
beta7 B-experimental-construct O 0.7233579754829407
construct O O 0.9352996349334717
bound O O 0.9599019289016724
8 O O 0.9686955213546753
. O O 0.9931383728981018
4 O O 0.9741520285606384
times O O 0.9867134094238281
more O O 0.9937132000923157
filamin B-protein-family O 0.7794997692108154
than O O 0.9921924471855164
the O O 0.9903538227081299
beta1A B-protein O 0.7335020303726196
model O O 0.9550129175186157
protein O O 0.9454550743103027
( O O 0.9771996140480042
Fig O O 0.8923165202140808
. O O 0.9920152425765991
8) O O 0.7540968656539917
. O O 0.9812175035476685

The O O 0.9752753973007202
fact O O 0.986586332321167
that O O 0.9946215152740479
deletion O O 0.8962616920471191
of O O 0.9912809729576111
domain B-protein-domain O 0.9153527021408081
7 I-protein-domain O 0.9649468064308167
did O O 0.9887722134590149
not O O 0.9945937991142273
affect O O 0.9859030246734619
the O O 0.9914268255233765
inhibition O O 0.9231525659561157
of O O 0.9901284575462341
osteoclastogenesis O O 0.7093423008918762
( O O 0.9670912027359009
Fig O O 0.866874098777771
. O O 0.9918256998062134
2 O O 0.9730209112167358
A O O 0.9886271357536316
) O O 0.9801812767982483
but O O 0.9942658543586731
significantly O O 0.9812237024307251
decreased O O 0.9762187004089355
the O O 0.9922149777412415
binding O O 0.9734660387039185
of O O 0.9912803769111633
OCIF B-protein O 0.7385867834091187
to O O 0.990017831325531
heparin B-chemical O 0.7554671764373779
( O O 0.9683588743209839
Fig O O 0.869875967502594
. O O 0.9919523596763611
3 O O 0.973957359790802
) O O 0.9793294668197632
indicates O O 0.9685209393501282
that O O 0.9947876930236816
binding O O 0.9740486145019531
ability O O 0.982579231262207
of O O 0.9913076758384705
OCIF O O 0.7390726208686829
to O O 0.9903297424316406
heparin O O 0.7825686931610107
does O O 0.9847909808158875
not O O 0.993854820728302
correlate O O 0.9361580610275269
with O O 0.9930701851844788
its O O 0.9893736243247986
osteoclastogenesis O O 0.7061810493469238
inhibitory O O 0.8295771479606628
activity O O 0.9827022552490234
in O O 0.9929870963096619
vitro O O 0.9444302320480347
. O O 0.9834923148155212

 O O 0.3460542559623718
p120ctn B-protein O 0.5546879768371582
inhibits O O 0.7862378358840942
Rho B-protein O 0.4457845687866211
( O O 0.955352783203125
Anastasiadis O B-protein 0.34354570508003235
et O O 0.9453120231628418
al O O 0.9708104133605957
. O O 0.994127631187439
, O O 0.9934465289115906
2000 O O 0.9734675288200378
; O O 0.9864277243614197
Noren O B-protein 0.39063605666160583
et O O 0.9505339860916138
al O O 0.9684251546859741
. O O 0.9934000968933105
, O O 0.991621732711792
2000) O O 0.7776926159858704
, O O 0.990632176399231
and O O 0.9912962913513184
cadherin B-protein-family B-protein 0.42556318640708923
binding O O 0.971796452999115
to O O 0.9915633201599121
p120ctn O O 0.746116578578949
functions O O 0.9776174426078796
as O O 0.9924936294555664
a O O 0.9884796738624573
regulator O O 0.8796489834785461
of O O 0.9911165237426758
adhesion O O 0.8659721612930298
through O O 0.9755844473838806
Rho B-protein-family B-protein 0.34529855847358704
GTPases I-protein-family O 0.4235599935054779
( O O 0.950302243232727
Anastasiadis O B-protein 0.3726588487625122
and O O 0.992379903793335
Reynolds O O 0.8933307528495789
, O O 0.9907088279724121
2001) O O 0.7534216046333313
. O O 0.9812341332435608

Pho B-protein B-protein 0.2268989384174347
and O O 0.9916051626205444
Phol B-protein O 0.7416263818740845
bind O O 0.9491814970970154
to O O 0.9939371347427368
the O O 0.9923654198646545
same O O 0.9886903762817383
DNA B-DNA O 0.9589647054672241
sequence O O 0.9459168314933777
phol O O 0.7422740459442139
is O O 0.9878494143486023
located O O 0.9620516300201416
on O O 0.9915845394134521
chromosome O O 0.9093430638313293
3 O O 0.9735327959060669
in O O 0.9907317757606506
polytene O O 0.6904057264328003
subdivision O O 0.7260423898696899
67B O O 0.7288611531257629
and O O 0.992265522480011
is O O 0.9906685948371887
designated O O 0.9493620991706848
by O O 0.9936855435371399
the O O 0.9909091591835022
Drosophila O O 0.8079274296760559
genome O O 0.8933097124099731
project O O 0.967063307762146
as O O 0.991449773311615
CG3445 O O 0.7497730255126953
. O O 0.9808399081230164

Cortactin B-protein O 0.395684152841568
Binds O O 0.8455735445022583
the O O 0.9872708320617676
Arp2/3 B-protein-complex B-protein 0.38652288913726807
Complex O O 0.9727852940559387
through O O 0.98699551820755
Sequences O O 0.9639423489570618
in O O 0.9937347769737244
the O O 0.9900844097137451
NTA B-protein-motif O 0.5082993507385254
Region O O 0.9470569491386414

Fig O O 0.6608715057373047
. O O 0.991313636302948
1 O O 0.98069828748703
shows O O 0.9829743504524231
that O O 0.9949846267700195
maximum O O 0.9716440439224243
pNPP B-chemical O 0.7098180055618286
hydrolysis O O 0.8582805395126343
is O O 0.9893163442611694
reached O O 0.9788170456886292
at O O 0.9905713796615601
an O O 0.9924240112304688
MKP3 B-protein O 0.7530725598335266
to O O 0.9903961420059204
ERK2 B-protein O 0.7223328948020935
ratio O O 0.95651775598526
of O O 0.9920278191566467
1 O O 0.9757530093193054
: O O 0.9827331304550171
1 O O 0.9774338603019714
, O O 0.9921886920928955
indicating O O 0.9713523983955383
a O O 0.9887170791625977
1 O O 0.9781129956245422
: O O 0.98405522108078
1 O O 0.9776557683944702
binding O O 0.9710941910743713
stoichiometry O O 0.7987129092216492
between O O 0.9903029799461365
MKP3 O O 0.7738370299339294
and O O 0.9917603731155396
ERK2 O O 0.7392234206199646
. O O 0.9804721474647522

The O O 0.9680344462394714
GST-Ena8 B-experimental-construct O 0.6937518119812012
P I-experimental-construct O 0.8435442447662354
→ I-experimental-construct O 0.7472372651100159
A I-experimental-construct O 0.9853869676589966
fusion O O 0.8902972936630249
protein O O 0.9484791159629822
and O O 0.9921022057533264
wild-type O O 0.6904849410057068
GST-Ena - O 0.6947962045669556
pulled O O 0.9028447866439819
down O O 0.9792811870574951
approximately O O 0.9711654782295227
equivalent O O 0.9646255970001221
amounts O O 0.9777680039405823
of O O 0.9890977144241333
chickadee B-protein B-protein 0.2843027114868164
( O O 0.9801539182662964
Fig O O 0.8619271516799927
. O O 0.9907853603363037
6) O O 0.7678810954093933
, O O 0.9907551407814026
suggesting O O 0.9773848652839661
that O O 0.9946330785751343
distinct O O 0.9768847227096558
amino O O 0.9370324611663818
acids O O 0.9663109183311462
may O O 0.992728590965271
be O O 0.9951884746551514
important O O 0.9899348616600037
for O O 0.9909111857414246
Ena O B-protein 0.5117807984352112
binding O O 0.9643447995185852
to O O 0.9918230175971985
profilin B-protein-family O 0.7574374675750732
and O O 0.9923185110092163
the O O 0.9894356727600098
Abl-SH3 B-protein-domain O 0.7116471529006958
domain O O 0.907940149307251
, O O 0.9912636280059814
despite O O 0.9881845712661743
the O O 0.9919028878211975
overlap O O 0.9691845178604126
observed O O 0.98150634765625
in O O 0.9935585856437683
some O O 0.9942790269851685
of O O 0.9937642812728882
their O O 0.992753803730011
putative O O 0.8109179735183716
binding O O 0.9717559218406677
sites O O 0.9744610786437988
. O O 0.9831699132919312

The O O 0.9696090817451477
ATP-bound - O 0.7470760345458984
form O O 0.9838554263114929
of O O 0.9891830086708069
Hsp70 B-protein B-protein 0.3590066134929657
binds O O 0.9046057462692261
and O O 0.9918578267097473
releases O O 0.9377380609512329
peptides O O 0.8869543671607971
rapidly O O 0.9751248359680176
, O O 0.9920346140861511
whereas O O 0.9714403748512268
the O O 0.9903117418289185
ADP-bound B-protein O 0.735167920589447
form I-protein O 0.9805561900138855
binds O O 0.8886961936950684
and O O 0.9928971529006958
releases O O 0.9490603804588318
them O O 0.9929389953613281
slowly O O 0.9686148762702942
( O O 0.9721584916114807
Palleros O O 0.7490479946136475
et O O 0.9378319978713989
al O O 0.969449520111084
. O O 0.9937384128570557
, O O 0.9931064248085022
1991 O O 0.9690277576446533
; O O 0.9888933300971985
Schmid O O 0.7891830801963806
et O O 0.9409672021865845
al O O 0.9702093005180359
. O O 0.9938133955001831
, O O 0.9930847883224487
1994 O O 0.969900369644165
; O O 0.9880913496017456
Szabo O O 0.6802397966384888
et O O 0.9395377039909363
al O O 0.9710314869880676
. O O 0.9941260814666748
, O O 0.9936006665229797
1994 O O 0.973404586315155
) O O 0.9815152883529663
. O O 0.9853237867355347

The O O 0.9744538068771362
initial O O 0.9722400903701782
steps O O 0.9771606922149658
in O O 0.9930102229118347
formation O O 0.9747709631919861
of O O 0.9930549263954163
the O O 0.9899221062660217
pre-initiation B-protein-complex O 0.7274725437164307
complex I-protein-complex O 0.9690260887145996
- O O 0.9775248765945435
binding O O 0.9727033376693726
of O O 0.9911518692970276
TFIID B-protein-complex O 0.735729992389679
and O O 0.9901309013366699
TFIIA B-protein O 0.7316249012947083
- O O 0.9745739102363586
are O O 0.9943521022796631
likely O O 0.9886966943740845
to O O 0.9942534565925598
be O O 0.9946188926696777
important O O 0.9882739782333374
determinants O O 0.8635154366493225
of O O 0.9927270412445068
this O O 0.9936195015907288
dynamic O O 0.9531195163726807
equilibrium O O 0.9649646878242493
. O O 0.9835025668144226

dASF1 B-protein O 0.4052540957927704
binds O O 0.861299455165863
directly O O 0.9853644967079163
to O O 0.9934638142585754
dCAF-1 B-protein O 0.7489765286445618
. O O 0.9807273149490356

 O O 0.37433066964149475
Castanospermine B-chemical O 0.6373618245124817
partially O O 0.9593629240989685
blocked O O 0.9583300352096558
the O O 0.9925988912582397
binding O O 0.9759966135025024
of O O 0.991891622543335
gp160 B-protein-complex O 0.7515528798103333
to O O 0.9907868504524231
calreticulin B-protein O 0.7415165901184082
and O O 0.9909091591835022
calnexin B-protein-family O 0.7550850510597229
, O O 0.9900310039520264
whereas O O 0.9653171300888062
1-deoxynojirimycin B-chemical O 0.7724378108978271
had O O 0.989404559135437
little O O 0.980571985244751
inhibitory O O 0.8652365207672119
effect O O 0.9858202934265137
. O O 0.9841667413711548

 O O 0.43731260299682617
Cell O O 0.9486176371574402
, O O 0.9919265508651733
78 O O 0.9290000796318054
, O O 0.9906646013259888
761-771 O O 0.7308000326156616
[ O O 0.9023645520210266
Medline O O 0.48204511404037476
] O O 0.8556172251701355
ubinfeld O O 0.7375249862670898
, O O 0.9890177249908447
B O O 0.8882709741592407
. O O 0.9925249814987183
, O O 0.9916350841522217
Albert O O 0.9167107343673706
, O O 0.9915986061096191
I O O 0.9868213534355164
. O O 0.9933164119720459
, O O 0.9909952282905579
Porfiri O O 0.7583150863647461
, O O 0.9894903302192688
E O O 0.8909329771995544
. O O 0.9920369386672974
, O O 0.9891490340232849
Fiol O B-protein 0.46517089009284973
, O O 0.9895514845848083
C O O 0.9007914662361145
. O O 0.9923810362815857
, O O 0.9908037185668945
Munemitso O O 0.7609744668006897
, O O 0.9896082282066345
S O O 0.8821306228637695
. O O 0.9922577738761902
and O O 0.9927566647529602
Polakis O O 0.7537748217582703
, O O 0.9891658425331116
P O O 0.8828123211860657
. O O 0.9921207427978516
( O O 0.9774094820022583
1996 O O 0.9665420651435852
) O O 0.979468584060669
Binding O O 0.9753256440162659
of O O 0.9918369650840759
GSK3beta B-protein O 0.7616219520568848
to O O 0.9922624826431274
the O O 0.9895821809768677
APC-beta-catenin - O 0.7345108985900879
complex O O 0.9715255498886108
and O O 0.9936876893043518
regulation O O 0.9736700057983398
of O O 0.9934410452842712
complex O O 0.9785954356193542
assembly O O 0.9735344052314758
. O O 0.9833426475524902

Since O O 0.9682084321975708
binding O O 0.9752492904663086
of O O 0.9920889139175415
NorpA B-protein O 0.7571607828140259
to O O 0.9907750487327576
InaD B-protein O 0.7457948327064514
is O O 0.988654613494873
critical O O 0.9799339771270752
for O O 0.991649866104126
phototransduction O O 0.7616526484489441
, O O 0.9908345937728882
we O O 0.9933152794837952
were O O 0.9942540526390076
interested O O 0.9703859686851501
in O O 0.9921148419380188
elucidating O O 0.8172296285629272
the O O 0.9905557036399841
structural O O 0.9636003971099854
determinants O O 0.850479781627655
of O O 0.9900817275047302
NorpA O O 0.722322940826416
- O O 0.9683136940002441
InaD O O 0.734061062335968
interaction O O 0.9677250981330872
through O O 0.9873077273368835
the O O 0.9920296669006348
structure O O 0.9786545634269714
of O O 0.9907060265541077
InaD O O 0.6867640614509583
PDZ1 B-protein-domain O 0.7176049947738647
in O O 0.9906919598579407
complex O O 0.9781427383422852
with O O 0.993992030620575
the O O 0.9914239048957825
C-terminus O O 0.7281736135482788
of O O 0.9899073839187622
NorpA O O 0.718805193901062
. O O 0.9792777895927429

This O O 0.9785206317901611
interaction O O 0.9733206629753113
seems O O 0.9837008118629456
to O O 0.9944500923156738
be O O 0.9945465326309204
mediated O O 0.9499155282974243
through O O 0.9839400053024292
Polalpha B-protein-complex O 0.7342464923858643
as O O 0.986610472202301
MBP B-protein B-protein 0.44208234548568726
alone O O 0.9758944511413574
did O O 0.9892393350601196
not O O 0.9946753978729248
bind O O 0.9587377309799194
to O O 0.9927928447723389
Swi6 B-protein O 0.734961986541748
. O O 0.9798832535743713

We O O 0.9776068925857544
found O O 0.9876197576522827
that O O 0.9955818057060242
both O O 0.9929312467575073
the O O 0.9910373687744141
wild-type O O 0.7559894323348999
and O O 0.9925612807273865
the O O 0.9904215335845947
triple O O 0.8755097985267639
mutant O O 0.8414934277534485
form O O 0.9838271141052246
of O O 0.9910402894020081
FKHRL1 B-protein O 0.7344699501991272
bound O O 0.9582122564315796
to O O 0.9934485554695129
the O O 0.9912759065628052
IRS B-DNA O 0.8946645855903625
of O O 0.9918217062950134
the O O 0.988906741142273
IGFBP1 B-DNA O 0.7050436735153198
gene I-DNA O 0.9243113398551941
, O O 0.991119921207428
leading O O 0.9789491891860962
to O O 0.9937531352043152
a O O 0.9886944890022278
shift O O 0.9694265723228455
in O O 0.9926856756210327
the O O 0.9915476441383362
mobility O O 0.9279342293739319
of O O 0.992512583732605
the O O 0.9906896352767944
IRS B-DNA O 0.8819564580917358
DNA I-DNA O 0.9574761986732483
element I-DNA O 0.9585118293762207
on O O 0.9924662709236145
a O O 0.9851348996162415
nondenaturing O O 0.6393088102340698
polyacrylamide O B-protein 0.4311476945877075
gel O O 0.8647016286849976
( O O 0.9729860424995422
Figure O O 0.9620410203933716
5B O B-protein 0.4572566747665405
, O O 0.9887012243270874
lanes O O 0.916314959526062
1 O O 0.9771371483802795
, O O 0.9925976991653442
2 O O 0.9776400327682495
, O O 0.9934373497962952
and O O 0.9937757253646851
3) O O 0.7506958246231079
. O O 0.9807816743850708

 O O 0.435749351978302
Hence O O 0.9618754386901855
, O O 0.9924309849739075
it O O 0.9943886399269104
can O O 0.9933536052703857
be O O 0.9950697422027588
predicted O O 0.9707390069961548
that O O 0.9932906627655029
BAG4 B-protein O 0.6883158087730408
binds O O 0.8405584096908569
Hsc70 B-protein O 0.7381893396377563
in O O 0.991374671459198
a O O 0.9895092248916626
manner O O 0.9866782426834106
analogous O O 0.9587399959564209
to O O 0.9926846027374268
BAG1 B-protein O 0.7503373622894287
( O O 0.9748929738998413
3 O O 0.9777211546897888
, O O 0.9916417598724365
15) O O 0.7563846111297607
. O O 0.9812286496162415

Dimerization O B-protein 0.3293372094631195
of O O 0.9876900911331177
RBP1 B-protein O 0.760205864906311
as O O 0.9909154772758484
detected O O 0.9629198312759399
in O O 0.9930204749107361
the O O 0.9891302585601807
two-hybrid O B-protein 0.40187790989875793
system O O 0.9815778136253357
is O O 0.9900340437889099
consistent O O 0.9793714284896851
with O O 0.9937881827354431
earlier O O 0.9858942031860352
indications O O 0.9612945318222046
for O O 0.992424726486206
cooperative O O 0.9445815682411194
binding O O 0.972841739654541
of O O 0.9915443658828735
RBP1 O O 0.7569607496261597
to O O 0.9918002486228943
multiple O O 0.9708724617958069
RBP1 O O 0.6749377250671387
RNA B-RNA O 0.7850908637046814
target O O 0.9643579125404358
sequences O O 0.9576894640922546
and O O 0.9942721128463745
with O O 0.9942296743392944
evidence O O 0.9904290437698364
for O O 0.9914717078208923
oligomerization O O 0.564791738986969
of O O 0.9886226058006287
RBP1 O O 0.7424010038375854
in O O 0.9897773861885071
gel-shift O O 0.7616034150123596
experiments O O 0.9738837480545044
( O O 0.9755474925041199
15) O O 0.7565516233444214
. O O 0.9814077019691467

Pbx B-protein-family B-protein 0.11155785620212555
Homologs O O 0.6590520739555359
Extradenticle B-protein O 0.6919655203819275
and O O 0.990967333316803
ceh-20 B-protein O 0.7641881108283997
Interact O O 0.9550839066505432
with O O 0.9927971959114075
Meis1 B-protein O 0.7958680391311646
to O O 0.9928674697875977
Cooperatively O O 0.9190507531166077
Bind O O 0.9062299132347107
CRS1 B-protein O 0.38102027773857117

( O O 0.9211506843566895
B O O 0.8735448122024536
) O O 0.9710980653762817
Clathrin B-protein B-protein 0.4044179618358612
binding O O 0.9704152345657349
to O O 0.9926623106002808
amphiphysin B-protein O 0.7427586913108826
. O O 0.9804917573928833

Finally O O 0.9054752588272095
, O O 0.9899550676345825
She2p B-protein O 0.7697758078575134
bound O O 0.9634144902229309
to O O 0.9938031435012817
the O O 0.9902063012123108
ASH1 B-RNA O 0.7169867157936096
transcript I-RNA O 0.8600334525108337
is O O 0.9894960522651672
required O O 0.9896794557571411
for O O 0.9938384890556335
the O O 0.9920639395713806
recruitment O O 0.9189428091049194
of O O 0.9905152320861816
She3p B-protein O 0.743232011795044
and O O 0.9916315674781799
subsequently O O 0.9606279730796814
She1p/Myo4p - O 0.7599698305130005
to O O 0.9923269152641296
form O O 0.9863508343696594
a O O 0.9885762333869934
mature O O 0.9611265659332275
transport O O 0.9661024808883667
particle O O 0.9328330159187317
( O O 0.9722460508346558
Munchow O O 0.7561683058738708
et O O 0.9399274587631226
al O O 0.9703126549720764
. O O 0.9938596487045288
, O O 0.9931502938270569
1999 O O 0.9687919616699219
; O O 0.9872809052467346
Bohl O O 0.5574662089347839
et O O 0.9316995143890381
al O O 0.9686927795410156
. O O 0.993575394153595
, O O 0.9929391145706177
2000 O O 0.9737359881401062
; O O 0.9908609390258789
Long O O 0.9869847893714905
et O O 0.9478025436401367
al O O 0.9700095057487488
. O O 0.9936729669570923
, O O 0.9929647445678711
2000 O O 0.9722267985343933
; O O 0.9870086312294006
Takizawa O B-protein 0.4463881850242615
and O O 0.992399275302887
Vale O O 0.8503461480140686
, O O 0.9918141961097717
2000 O O 0.9747198820114136
) O O 0.981331467628479
. O O 0.9853085875511169

The O O 0.9658109545707703
EH B-protein-domain O 0.672046959400177
domain O O 0.9158565998077393
of O O 0.9908955693244934
POB1 B-protein O 0.7476294040679932
bound O O 0.9605389833450317
directly O O 0.9849509000778198
to O O 0.9931824803352356
Epsin B-protein-family O 0.773002028465271
and O O 0.9916198253631592
Eps15 B-protein O 0.7337805032730103
. O O 0.9801127910614014

Heparin-binding - O 0.44886162877082825
activity O O 0.9750335812568665
of O O 0.9900807738304138
apoE B-protein B-protein 0.4676045775413513
was O O 0.9846854209899902
also O O 0.990193784236908
proposed O O 0.981913149356842
to O O 0.994170606136322
be O O 0.9947181344032288
responsible O O 0.9818151593208313
for O O 0.9933292865753174
the O O 0.9907262325286865
inhibitory O O 0.8398934602737427
role O O 0.9779611229896545
of O O 0.9894445538520813
apoE O B-protein 0.4544311761856079
in O O 0.9907117486000061
cell O O 0.9614740014076233
growth O O 0.9848579168319702
[ O O 0.9441149830818176
8 O O 0.9691739082336426
. O O 0.9840927124023438

Despite O O 0.9647443294525146
the O O 0.9923983216285706
higher O O 0.9884797930717468
abundance O O 0.9636998176574707
of O O 0.9917579293251038
PTBΔ B-protein O 0.7641061544418335
in O O 0.9915127158164978
the O O 0.9897252321243286
IP B-assay O 0.7590907216072083
pellet O O 0.6790257096290588
( O O 0.9698241949081421
Figure O O 0.9592380523681641
6B O B-protein 0.39471760392189026
, O O 0.9911462664604187
compare O O 0.9517101049423218
lane O O 0.9131289720535278
12 O O 0.9770864844322205
to O O 0.9930471777915955
lane O O 0.8933548331260681
10) O O 0.7467153072357178
, O O 0.9906015396118164
no O O 0.991647481918335
binding O O 0.9750169515609741
of O O 0.9915497303009033
PTBΔ O O 0.7388432025909424
to O O 0.9893702268600464
MSE1-4 B-experimental-construct O 0.6741486191749573
RNA I-experimental-construct O 0.8013011813163757
could O O 0.9910945892333984
be O O 0.9943516254425049
detected O O 0.9614934325218201
by O O 0.9920067191123962
UV B-process O 0.8133924007415771
crosslinking O O 0.6885004639625549
, O O 0.989982545375824
while O O 0.9910159111022949
binding O O 0.9732104539871216
of O O 0.9895732998847961
PTB B-protein B-protein 0.3919254243373871
was O O 0.9895618557929993
clearly O O 0.9811448454856873
and O O 0.9940973520278931
consistently O O 0.9700642228126526
detected O O 0.9590746760368347
( O O 0.9768097996711731
Figure O O 0.9616061449050903
6B O B-protein 0.4008271396160126
, O O 0.9915857315063477
compare O O 0.9536688923835754
lanes O O 0.9232878088951111
4 O O 0.9738115072250366
and O O 0.9934061765670776
6) O O 0.7538325786590576
. O O 0.9810938835144043

On O O 0.9768819212913513
binding O O 0.9748650193214417
of O O 0.9920475482940674
LPS B-chemical O 0.7918158769607544
to O O 0.9904323220252991
TLRs B-protein-family O 0.5421254634857178
, O O 0.9887899160385132
specifically O O 0.9756426811218262
TLR2 O O 0.7488227486610413
and O O 0.9894111752510071
TLR4 O B-protein 0.4221057891845703
, O O 0.9895427227020264
via O O 0.9405336976051331
CD14 B-protein B-protein 0.35545846819877625
, O O 0.9920478463172913
a O O 0.9884623885154724
number O O 0.9882702827453613
of O O 0.9926060438156128
molecules O O 0.9668501019477844
are O O 0.9938667416572571
recruited O O 0.9148683547973633
to O O 0.9932456612586975
the O O 0.9903568625450134
receptor O O 0.8682510256767273
to O O 0.9912840127944946
mediate O O 0.8914597630500793
NF-κB B-protein-complex O 0.6461746692657471
activation O O 0.9106850624084473
, O O 0.9912086725234985
which O O 0.9935829043388367
include O O 0.9860579371452332
the O O 0.9886234998703003
adaptor O B-protein 0.49879103899002075
molecule O O 0.8499106764793396
MyD88 B-protein O 0.7373694777488708
, O O 0.9903059005737305
the O O 0.9903220534324646
protein O O 0.918934166431427
kinase O O 0.5413112044334412
IRAK B-protein B-protein 0.4193113446235657
, O O 0.9896043539047241
and O O 0.9937863349914551
the O O 0.9890182018280029
adaptor O O 0.5038713216781616
molecule O O 0.8497099876403809
TRAF-6 B-protein O 0.7336589694023132
, O O 0.9900884032249451
thus O O 0.9872899651527405
forming O O 0.9725842475891113
the O O 0.9903308153152466
receptor O O 0.861785352230072
complex O O 0.9685010313987732
[ O O 0.9209602475166321
29] O O 0.7487936019897461
, O O 0.99029141664505
resulting O O 0.9817523956298828
in O O 0.9928216338157654
interaction O O 0.973256528377533
of O O 0.9918944239616394
downstream O O 0.920543909072876
molecules O O 0.9657585620880127
and O O 0.9941591024398804
the O O 0.9926134347915649
subsequent O O 0.9736213684082031
activation O O 0.9312976598739624
of O O 0.9904834032058716
NF-κB O O 0.6718459725379944
. O O 0.9784723520278931

Hence O O 0.9218354821205139
, O O 0.9922256469726562
we O O 0.9936822652816772
speculated O O 0.9484796524047852
that O O 0.994103729724884
p140mDia B-protein O 0.7701029777526855
might O O 0.9866532683372498
bind O O 0.9557908177375793
to O O 0.9926673769950867
profilin B-protein-family O 0.7359731793403625
. O O 0.9799900650978088

For O O 0.9782560467720032
example O O 0.9858673214912415
, O O 0.9928250312805176
additional O O 0.9829156398773193
interactions O O 0.9776085615158081
between O O 0.9928156137466431
the O O 0.9900886416435242
β3-β4 B-protein-region O 0.7033142447471619
loop I-protein-region O 0.8634841442108154
and O O 0.9910456538200378
Ins(1 B-chemical O 0.75242018699646
, I-chemical O 0.9900873303413391
3 I-chemical O 0.9749661684036255
, I-chemical O 0.9920819997787476
4 I-chemical O 0.9721255898475647
, I-chemical O 0.9908145070075989
5)P4 I-chemical O 0.7683075070381165
also O O 0.9887470602989197
contribute O O 0.9760521650314331
to O O 0.9925475716590881
high‐affinity O O 0.7481586933135986
binding O O 0.9687645435333252
of O O 0.9914219975471497
PH B-protein-domain O 0.888314962387085
domains I-protein-domain O 0.9161487817764282
to O O 0.990199089050293
PI3K B-protein-family B-protein 0.4380156695842743
products O O 0.9790312647819519
; O O 0.987257182598114
K53 B-amino-acid O 0.7527451515197754
in O O 0.988243579864502
BTK B-protein O 0.49617621302604675
is O O 0.9875248670578003
critical O O 0.9816572666168213
for O O 0.9934152364730835
the O O 0.9904014468193054
BTK‐PH B-protein-domain O 0.7201741337776184
domain I-protein-domain O 0.9092252850532532
to O O 0.9919425249099731
bind O O 0.9380944967269897
PtdIns(3 B-chemical O 0.7505576610565186
, I-chemical O 0.9904084205627441
4 I-chemical O 0.9725514054298401
, I-chemical O 0.9909261465072632
5)P3 I-chemical O 0.7447766065597534
( O O 0.9651669859886169
Hyvonen O B-protein 0.4610483646392822
et O O 0.9364281892776489
al O O 0.9719027280807495
. O O 0.9942411184310913
, O O 0.9923048615455627
1995) O O 0.7615721821784973
. O O 0.981438934803009

The O O 0.9756744503974915
fact O O 0.9862756729125977
that O O 0.9929893016815186
CKI B-protein-family B-protein 0.4091472327709198
binding O O 0.9734008312225342
of O O 0.9905844330787659
dPER B-protein O 0.7397419810295105
and O O 0.9904911518096924
mPER1 B-protein O 0.7483127117156982
has O O 0.9883991479873657
been O O 0.9916623830795288
preserved O O 0.9611599445343018
while O O 0.9915673136711121
the O O 0.9921647310256958
location O O 0.9735727906227112
and O O 0.9931604862213135
sequence O O 0.9578278064727783
of O O 0.9926880598068237
the O O 0.9911419153213501
binding O O 0.9702486991882324
site O O 0.9636052846908569
may O O 0.9915483593940735
have O O 0.9941338896751404
been O O 0.9909018278121948
shuffled O O 0.78652024269104
suggests O O 0.9696452021598816
there O O 0.992081880569458
is O O 0.9906558394432068
strong O O 0.9844560623168945
selective O O 0.9574031829833984
pressure O O 0.9842122197151184
to O O 0.9935021996498108
maintain O O 0.9769225120544434
the O O 0.9915174841880798
interaction O O 0.9731029868125916
of O O 0.993390679359436
the O O 0.9925810098648071
two O O 0.9921281337738037
proteins O O 0.9629331827163696
. O O 0.9831548929214478

To O O 0.9800352454185486
demonstrate O O 0.9765307307243347
that O O 0.9951966404914856
the O O 0.9925271272659302
reduction O O 0.9791672229766846
in O O 0.993109941482544
the O O 0.9921584129333496
amount O O 0.9832119345664978
of O O 0.991055965423584
Axin B-protein O 0.7224234342575073
bound O O 0.9541479349136353
to O O 0.9915361404418945
Xgsk-3 B-protein O 0.7450476884841919
is O O 0.9882574677467346
specifically O O 0.979150116443634
dependent O O 0.9753490090370178
on O O 0.9902847409248352
GBP B-protein-family O 0.63121098279953
binding O O 0.9671673774719238
to O O 0.9921028017997742
Xgsk-3 O O 0.7580621242523193
, O O 0.9904178977012634
the O O 0.9900437593460083
coimmunoprecipitation O O 0.7329428791999817
experiment O O 0.943520188331604
was O O 0.9887136220932007
repeated O O 0.9772264957427979
using O O 0.9870585799217224
a O O 0.9897968173027039
high O O 0.9821140170097351
dose O O 0.928557813167572
of O O 0.9898735284805298
HA-tagged B-fusion-protein O 0.6479873061180115
GBP I-fusion-protein O 0.5402936339378357
( O O 0.9618967175483704
GBPwt B-fusion-protein O 0.7445542216300964
) O O 0.9762993454933167
or O O 0.993259847164154
an O O 0.9938212633132935
equivalent O O 0.966315746307373
amount O O 0.9850978851318359
of O O 0.993340790271759
the O O 0.9890627264976501
HA-tagged B-fusion-protein O 0.6368603706359863
GBP I-fusion-protein O 0.5194271802902222
mutant I-fusion-protein O 0.8252456784248352
that O O 0.9939563870429993
does O O 0.9882112145423889
not O O 0.9940423369407654
bind O O 0.9418289065361023
Xgsk-3 O O 0.7279763221740723
( O O 0.9684505462646484
Yost O O 0.7677550911903381
et O O 0.9434360861778259
al O O 0.9721429347991943
. O O 0.9939800500869751
1998 O O 0.9714189767837524
) O O 0.9818727374076843
( O O 0.9778373837471008
GBPmut) - O 0.7639912366867065
. O O 0.9817333221435547

As O O 0.9775736331939697
shown O O 0.9855592250823975
in O O 0.9934794902801514
Figure O O 0.9694450497627258
​7A O O 0.7559995651245117
( O O 0.9739392399787903
panels O O 0.9521917104721069
labeled O O 0.9093580842018127
‘GAL4 O O 0.736644983291626
’ O O 0.9420206546783447
) O O 0.9794474840164185
, O O 0.9907339811325073
GAL4 B-protein-region O 0.7056611776351929
WT I-protein-region O 0.5776137709617615
, O O 0.9872708320617676
DB·CR B-protein-region O 0.7566176056861877
and O O 0.9909760355949402
DB·AD B-protein-region O 0.7438990473747253
bound O O 0.9591706395149231
more O O 0.9937072396278381
readily O O 0.9684532880783081
than O O 0.9931682348251343
the O O 0.9887267351150513
DNA-binding - B-protein 0.4751430153846741
domain O O 0.9036295413970947
alone O O 0.9746271371841431
to O O 0.9935978651046753
an O O 0.9927709698677063
artificial O O 0.9549323320388794
promoter O O 0.8073464632034302
, O O 0.9909449815750122
which O O 0.9931992888450623
bears O O 0.9625772833824158
four O O 0.9854665994644165
GAL4 B-DNA O 0.7529895901679993
sites I-DNA O 0.9689782857894897
fused O O 0.9071138501167297
to O O 0.994021475315094
an O O 0.9937735795974731
unrelated O O 0.9562280178070068
HIS4 B-DNA O 0.7256556749343872
basal I-DNA O 0.8878752589225769
promoter I-DNA O 0.7912091016769409
. O O 0.9810361862182617

 O O 0.4659644663333893
In O O 0.989725649356842
either O O 0.989473283290863
case O O 0.9873484373092651
, O O 0.9927484393119812
the O O 0.9922899603843689
regulation O O 0.970778226852417
of O O 0.992893636226654
the O O 0.9916312098503113
balance O O 0.9772966504096985
of O O 0.9930232763290405
the O O 0.9916479587554932
binding O O 0.9712177515029907
of O O 0.9889784455299377
Dvl B-protein B-protein 0.3396740257740021
and O O 0.9934378266334534
Axam B-protein O 0.7396034598350525
to O O 0.9909083247184753
Axin B-protein O 0.7666083574295044
is O O 0.9902299046516418
important O O 0.9895166754722595
. O O 0.984512984752655

 O O 0.4188646078109741
( O O 0.9622035622596741
B O O 0.8879458904266357
) O O 0.9798847436904907
The O O 0.9913045167922974
transcriptional O O 0.7897067666053772
activation O O 0.9248209595680237
of O O 0.992224931716919
the O O 0.988949179649353
TCF B-protein-family O 0.5717259645462036
reporter O O 0.9069202542304993
was O O 0.9870785474777222
inhibited O O 0.9234817624092102
by O O 0.9900469183921814
12S B-protein B-protein 0.5001076459884644
E1A I-protein O 0.7056698203086853
, O O 0.9903430938720703
but O O 0.9944167137145996
not O O 0.994902491569519
by O O 0.9926336407661438
mutant B-protein O 0.8314792513847351
E1A I-protein O 0.7456216812133789
that O O 0.993873119354248
does O O 0.988499104976654
not O O 0.994090735912323
bind O O 0.93355792760849
p300 B-protein O 0.48207882046699524
. O O 0.9764665365219116

Conversely O O 0.8169502019882202
, O O 0.9904695153236389
insertion O O 0.905480146408081
of O O 0.9933213591575623
this O O 0.9940987825393677
region O O 0.9849869608879089
from O O 0.9872552156448364
HRG B-protein B-protein 0.332796573638916
into O O 0.9846055507659912
EGF B-protein B-protein 0.46260613203048706
greatly O O 0.9674660563468933
diminishes O O 0.8686770796775818
binding O O 0.9727716445922852
to O O 0.993599534034729
the O O 0.9881332516670227
EGF B-protein B-protein 0.4395802319049835
receptor I-protein O 0.8588074445724487
( O O 0.9753414988517761
15 O O 0.9823728203773499
, O O 0.9917307496070862
31) O O 0.7564796209335327
. O O 0.9812000393867493

pRB B-protein B-protein 0.16346092522144318
remains O O 0.9767317771911621
hypophosphorylated O O 0.7621582746505737
and O O 0.9928054213523865
bound O O 0.9674906134605408
to O O 0.9928455948829651
E2Fs B-protein-family O 0.7643440365791321
, O O 0.9905565977096558
and O O 0.9925739765167236
E2F-responsive - O 0.7469466328620911
genes O O 0.965747594833374
remain O O 0.9859448671340942
repressed O O 0.9308262467384338
in O O 0.9928760528564453
early O O 0.9836314916610718
G1 B-cell O 0.5632152557373047
phase O O 0.9571514129638672
of O O 0.9907454252243042
p16-minus B-cell O 0.7325247526168823
tumor I-cell O 0.9296063780784607
cells I-cell O 0.9774833917617798
. O O 0.9840828776359558

 O O 0.3932804763317108
Buffers O O 0.7781339287757874
contained O O 0.9683408737182617
10 O O 0.9787197709083557
muM O O 0.6678668260574341
FAD B-chemical O 0.6770854592323303
; O O 0.9875103235244751
binding O O 0.9756351113319397
was O O 0.9900730848312378
carried O O 0.9842180013656616
out O O 0.9906849265098572
at O O 0.9905968904495239
40 O O 0.9701528549194336
mM O O 0.939490556716919
imidazole B-chemical B-protein 0.46609047055244446
, O O 0.9890859127044678
washing O O 0.9230895638465881
at O O 0.9894253015518188
60 O O 0.9693858027458191
mM O O 0.9605453610420227
, O O 0.9921827912330627
and O O 0.9924097061157227
elution O O 0.5286610126495361
at O O 0.9853076934814453
400 O O 0.944028913974762
mM O O 0.9590381383895874
for O O 0.9934453964233398
the O O 0.9925493001937866
first O O 0.9864361882209778
cycle O O 0.9622726440429688
and O O 0.9934636950492859
300 O O 0.9632186889648438
mM O O 0.9630202054977417
for O O 0.9941574335098267
the O O 0.9933943152427673
second O O 0.9823243618011475
. O O 0.983623743057251

( O O 0.931964635848999
A O O 0.988908588886261
) O O 0.9827420115470886
Specific O O 0.9907416105270386
binding O O 0.9776301383972168
of O O 0.992420494556427
tomosyn B-protein O 0.7691171765327454
to O O 0.9912400841712952
syntaxin-1a B-protein O 0.7245379090309143
. O O 0.9795645475387573

The O O 0.9692723155021667
“active O O 0.7336516976356506
” O O 0.9660399556159973
lipids B-chemical O 0.9207245111465454
include O O 0.9858002662658691
both O O 0.9899202585220337
esterified O O 0.5250731110572815
and O O 0.9891622066497803
unesterified O O 0.675825834274292
peroxidized B-chemical O 0.6770631670951843
lipids I-chemical O 0.8928502798080444
, O O 0.9896895885467529
lysoPtdCho B-chemical O 0.7597223520278931
, O O 0.9886777997016907
cholesterol B-chemical O 0.8781018257141113
oxidation O O 0.9441207051277161
products O O 0.9817373752593994
, O O 0.9912219047546387
aldehydes B-chemical O 0.8896117210388184
derived O O 0.974516749382019
from O O 0.991612434387207
breakdown O O 0.9555518627166748
of O O 0.9926843047142029
both O O 0.9888498187065125
esterified O B-protein 0.498892605304718
and O O 0.9887162446975708
unesterified O O 0.6584599614143372
oxidized O O 0.7663299441337585
fatty B-chemical O 0.8875985741615295
acids I-chemical O 0.9650769233703613
, O O 0.9927807450294495
and O O 0.9943388104438782
perhaps O O 0.9816462397575378
proteolipids B-chemical O 0.7764353156089783
that O O 0.9941838383674622
may O O 0.9923139214515686
have O O 0.9932629466056824
peroxidized O O 0.7284780144691467
lipids O O 0.8988066911697388
bound O O 0.965573251247406
to O O 0.9932906627655029
fragmented O O 0.9054720401763916
apoB-100 B-protein O 0.725093424320221
. O O 0.9799939393997192

If O O 0.9725560545921326
transcription O O 0.8913957476615906
of O O 0.9924266338348389
a O O 0.9881585240364075
target O O 0.9678514003753662
gene O O 0.9377503395080566
is O O 0.9902121424674988
not O O 0.9941924214363098
initiated O O 0.9492908716201782
in O O 0.9925988912582397
a O O 0.9882787466049194
cell O O 0.9577099084854126
, O O 0.9864720106124878
PcG B-protein-family B-protein 0.3314073085784912
proteins O O 0.9686331152915955
bound O O 0.963375985622406
to O O 0.9937916398048401
the O O 0.9913956522941589
gene O O 0.9359768033027649
' O O 0.9635387659072876
s O O 0.8583332896232605
PRE B-DNA O 0.9167603850364685
chromatin O O 0.7057355642318726
form O O 0.9833536148071289
a O O 0.9874372482299805
silencing O O 0.8523086309432983
structure O O 0.9782022833824158
that O O 0.9937841892242432
supersedes O O 0.7606053948402405
colocalized O O 0.604424238204956
TRX B-protein B-protein 0.3047320246696472
( O O 0.9755128026008606
P O O 0.8667563199996948
OUX O O 0.7587791681289673
et O O 0.9454740881919861
al O O 0.9736887216567993
. O O 0.9943276047706604
1996 O O 0.974187970161438
) O O 0.9821100831031799
. O O 0.985630214214325

HSP27 B-protein O 0.4117201864719391
binds O O 0.8670098185539246
to O O 0.9935263395309448
the O O 0.9879487752914429
26S B-protein-complex B-protein 0.2891508638858795
proteasome I-protein-complex O 0.568719208240509
complex I-protein-complex O 0.9654008150100708
. O O 0.982796311378479

The O O 0.9679700136184692
C-terminal O O 0.7442783713340759
domain O O 0.9147067070007324
of O O 0.9907167553901672
SAF-A B-protein O 0.7517001628875732
also O O 0.9876967072486877
contains O O 0.9685115814208984
the O O 0.9901404976844788
RGG-box B-protein-motif O 0.7528865337371826
, O O 0.9903383851051331
involved O O 0.9857615232467651
in O O 0.9929448962211609
binding O O 0.9736514687538147
to O O 0.9919306635856628
RNA B-RNA O 0.8001033067703247
( O O 0.9686146974563599
35) O O 0.760658860206604
, O O 0.9906300902366638
suggesting O O 0.9767636060714722
that O O 0.993742048740387
RNA O O 0.8237516283988953
and O O 0.9904819130897522
p300 B-protein O 0.5352068543434143
binding O O 0.9656935334205627
to O O 0.9924752116203308
SAF-A O O 0.779032289981842
are O O 0.994025707244873
mutually O O 0.974791944026947
exclusive O O 0.936591625213623
. O O 0.9831113815307617

At O O 0.967985987663269
0 O O 0.9408972263336182
. O O 0.9891112446784973
085 O B-protein 0.2439170479774475
ionic O O 0.9391061663627625
strength O O 0.9741067290306091
, O O 0.988457977771759
tropomyosin B-protein-family B-protein 0.3953879177570343
remained O O 0.9800662994384766
bound O O 0.9648382663726807
to O O 0.9936995506286621
the O O 0.9905151128768921
actin B-protein O 0.7949764132499695
at O O 0.988793671131134
the O O 0.9918638467788696
very O O 0.9908514618873596
low O O 0.9788452386856079
concentrations O O 0.9564548134803772
employed O O 0.978253185749054
in O O 0.9931025505065918
the O O 0.9904941916465759
motility O O 0.8106536865234375
assay O O 0.8296923041343689
, O O 0.9906442165374756
provided O O 0.9805355072021484
that O O 0.9951218962669373
the O O 0.991835355758667
proteins O O 0.9632052183151245
were O O 0.9916931986808777
premixed O O 0.5264848470687866
at O O 0.9827545285224915
10× O O 0.6872447729110718
assay O O 0.8060202598571777
concentration O O 0.949369490146637
( O O 0.9747328162193298
100 O O 0.9699767231941223
nM O O 0.906951367855072
of O O 0.9925824403762817
each O O 0.9893531799316406
) O O 0.9796603322029114
and O O 0.9941418766975403
then O O 0.9882083535194397
diluted O O 0.9452956914901733
immediately O O 0.9819552302360535
prior O O 0.9797700643539429
to O O 0.992607831954956
infusion O O 0.7994533181190491
into O O 0.9857599139213562
the O O 0.9916068315505981
flow O O 0.9741089940071106
cell O O 0.9591249227523804
. O O 0.9823717474937439

It O O 0.9789984822273254
has O O 0.9909062385559082
been O O 0.9929823875427246
shown O O 0.9850127696990967
that O O 0.9936462640762329
APC B-protein O 0.7080420255661011
makes O O 0.9693590998649597
a O O 0.9876449704170227
complex O O 0.975222647190094
with O O 0.9911925196647644
beta-catenin B-protein O 0.5973224639892578
and O O 0.992095410823822
that O O 0.9948705434799194
the O O 0.9913238286972046
phosphorylation O O 0.8876534104347229
of O O 0.9897164702415466
APC O O 0.6985820531845093
by O O 0.9898042678833008
GSK-3beta B-protein O 0.7489246129989624
increases O O 0.9795494675636292
the O O 0.9918521046638489
binding O O 0.9740135669708252
of O O 0.9912241697311401
APC O O 0.7124317288398743
to O O 0.9897123575210571
beta-catenin O O 0.5295559763908386
( O O 0.9655086994171143
37) O O 0.7359092235565186
. O O 0.9805781841278076

LPS-induced - O 0.41815024614334106
gene O O 0.916612446308136
expression O O 0.9762367606163025
of O O 0.9910092353820801
TNF-alpha B-gene B-protein 0.4561043977737427
and O O 0.9907903671264648
IL-1beta B-gene O 0.7498636841773987
is O O 0.9882727265357971
mediated O O 0.9493013620376587
by O O 0.9910174608230591
DNA-binding - O 0.5511078238487244
of O O 0.9889339804649353
NF-kappaB B-protein O 0.7597106099128723
to O O 0.9925454258918762
the O O 0.9888545274734497
TNF-alpha O B-protein 0.43357956409454346
and O O 0.9900264739990234
IL-1beta B-DNA O 0.6181138753890991
promotors I-DNA B-protein 0.309896320104599
( O O 0.9718756675720215
13) O O 0.7339991331100464
. O O 0.9808536767959595

Although O O 0.9678281545639038
stable O O 0.9697492122650146
binding O O 0.975925087928772
of O O 0.990254819393158
MDH B-protein-family B-protein 0.3644077479839325
to O O 0.9927149415016174
HSP18 B-protein O 0.7378914952278137
. I-protein O 0.9909222722053528
1 I-protein O 0.9778351187705994
was O O 0.9900581240653992
not O O 0.9945482611656189
detected O O 0.961256742477417
below O O 0.9801488518714905
40°C O O 0.7696872353553772
by O O 0.9918612241744995
SEC B-assay O 0.9129766225814819
( O O 0.9749140739440918
Figure O O 0.9677481055259705
2) O O 0.776046633720398
, O O 0.990928590297699
substantial O O 0.9698411226272583
bis-ANS B-experiment-tag O 0.7418208122253418
labeling O O 0.9324765801429749
of O O 0.9887402653694153
MDH O B-protein 0.3499990403652191
at O O 0.989155113697052
38°C O O 0.7418063879013062
suggested O O 0.9773958325386047
that O O 0.9949252605438232
, O O 0.9928314685821533
at O O 0.9914262294769287
this O O 0.9938814640045166
temperature O O 0.977334201335907
, O O 0.9883812069892883
MDH O B-protein 0.37081190943717957
was O O 0.9896570444107056
partially O O 0.9622792601585388
unfolded O O 0.9248698353767395
and O O 0.9939762353897095
may O O 0.9928394556045532
have O O 0.994364857673645
bound O O 0.9603400826454163
HSP18 O O 0.7572201490402222
. O O 0.9910843372344971
1 O O 0.9726933836936951
reversibly O O 0.7628746628761292
, O O 0.9911002516746521
thereby O O 0.9719911217689514
limiting O O 0.9631121754646301
bis-ANS O O 0.7659111618995667
binding O O 0.970136821269989
. O O 0.9833959341049194

Rapid O O 0.8827179074287415
regulation O O 0.9687073230743408
of O O 0.991684079170227
Cdk5 B-protein O 0.7590633630752563
activity O O 0.9806561470031738
could O O 0.9924367070198059
occur O O 0.991137683391571
by O O 0.9940211176872253
increased O O 0.987782895565033
binding O O 0.9749374985694885
of O O 0.9923509955406189
free O O 0.9680320024490356
p35 B-protein B-protein 0.3964056670665741
to O O 0.9905547499656677
monomeric O O 0.5407100319862366
Cdk5 O O 0.7011655569076538
, O O 0.9900521636009216
particularly O O 0.9890852570533752
as O O 0.9934052228927612
the O O 0.9928674697875977
generally O O 0.9894653558731079
low O O 0.9758862853050232
cytoplasmic O O 0.7704286575317383
levels O O 0.979647159576416
of O O 0.9888032078742981
p35 O B-protein 0.38625964522361755
( O O 0.9775083065032959
30 O O 0.979600727558136
, O O 0.9915001392364502
54 O O 0.9375184774398804
) O O 0.9796473979949951
are O O 0.9951826930046082
under O O 0.9915866851806641
strict O O 0.9805483818054199
regulation O O 0.9728549122810364
, O O 0.9926958084106445
with O O 0.9933039546012878
rapid O O 0.9448289275169373
p35 O B-protein 0.3710209131240845
turnover O O 0.9352155923843384
( O O 0.968305766582489
half-life O O 0.7648463249206543
20–30 O O 0.6869621872901917
min O O 0.7818527221679688
) O O 0.9774565100669861
controlled O O 0.9764313697814941
by O O 0.99429851770401
a O O 0.9883061051368713
ubiquitin-proteasome - O 0.7524402737617493
pathway O O 0.9333255887031555
( O O 0.9733480215072632
27) O O 0.7503788471221924
. O O 0.9811465740203857

Although O O 0.9675179719924927
the O O 0.9903590083122253
E1A B-protein O 0.7663509249687195
data O O 0.9809000492095947
are O O 0.9945066571235657
consistent O O 0.9798245429992676
with O O 0.9938644766807556
this O O 0.9941064119338989
view O O 0.9836910963058472
, O O 0.9903733730316162
E1A O O 0.7457650899887085
also O O 0.9854352474212646
binds O O 0.8593186736106873
p107 B-protein O 0.7276749610900879
and O O 0.9904431700706482
p130 B-protein O 0.754123330116272
, O O 0.9905334711074829
and O O 0.9939209222793579
these O O 0.9937115907669067
proteins O O 0.9647037982940674
can O O 0.9924537539482117
also O O 0.9909544587135315
associate O O 0.9552204012870789
with O O 0.9901184439659119
E2F B-DNA B-protein 0.3939628005027771
target I-DNA O 0.9681790471076965
promoters I-DNA O 0.8382531404495239
in O O 0.9887387752532959
senescent O O 0.4685607850551605
cells O O 0.969661295413971
. O O 0.9829266667366028

After O O 0.9614342451095581
cleavage O O 0.8415586948394775
there O O 0.9921104311943054
was O O 0.9903970956802368
a O O 0.9901456236839294
dramatic O O 0.9744398593902588
increase O O 0.9884383082389832
in O O 0.9901049733161926
talin B-protein-family B-protein 0.4507865309715271
binding O O 0.9719393253326416
to O O 0.9932200908660889
the O O 0.9897333979606628
beta3 B-protein O 0.708355724811554
tail O O 0.9075461626052856
( O O 0.9715608358383179
Fig O O 0.8782090544700623
. O O 0.9926405549049377
5 O O 0.9777104258537292
, O O 0.9933896064758301
A O O 0.9910270571708679
and O O 0.9936648607254028
B) O O 0.7482629418373108
. O O 0.9806463718414307

Binding O O 0.9231476783752441
of O O 0.9916732907295227
PC B-protein-family O 0.8278149366378784
and O O 0.9905894994735718
GAF B-protein-family B-protein 0.4469968378543854
to O O 0.9919849038124084
the O O 0.9878137111663818
hh B-DNA B-protein 0.4737090766429901
genomic I-DNA O 0.7681699395179749
region I-DNA O 0.9834587574005127
in O O 0.9934873580932617
embryos O O 0.9753429889678955
. O O 0.9846963882446289

Interestingly O O 0.7842994928359985
, O O 0.9915233850479126
both O O 0.9917927384376526
Oct-1 B-protein O 0.7667346596717834
and O O 0.9899026155471802
Pbx B-protein B-protein 0.48624059557914734
binding O O 0.9663347601890564
to O O 0.9933772683143616
the O O 0.9895703792572021
PRL3 B-DNA O 0.6911852955818176
nGRE I-DNA O 0.7224999666213989
were O O 0.9921715259552002
found O O 0.9878532886505127
to O O 0.9946680068969727
be O O 0.9953136444091797
required O O 0.9903327822685242
for O O 0.9916850328445435
glucocorticoid B-chemical O 0.5720667839050293
repression O O 0.9460798501968384
. O O 0.9820114374160767

SRF B-protein B-protein 0.12748076021671295
bound O O 0.9667274355888367
to O O 0.9916967153549194
GST-Hop - O 0.7437623143196106
( O O 0.9707414507865906
lane O O 0.9076420068740845
2 O O 0.9707321524620056
) O O 0.9810071587562561
but O O 0.994877278804779
not O O 0.9950683116912842
to O O 0.992745041847229
GST O O 0.5910423398017883
alone O O 0.972123384475708
( O O 0.9759316444396973
lane O O 0.9013254642486572
1) O O 0.731227695941925
. O O 0.9804822206497192

In O O 0.978890597820282
the O O 0.9922515749931335
presence O O 0.9803686738014221
of O O 0.9917194843292236
caldesmon B-protein O 0.7415003180503845
, O O 0.9881443977355957
fascin B-protein-family O 0.7525291442871094
does O O 0.9848440289497375
not O O 0.9933359622955322
inhibit O O 0.9303773641586304
actin B-protein-family O 0.7828793525695801
binding O O 0.9707943797111511
of O O 0.9927869439125061
high O O 0.9797690510749817
Mr O O 0.8998264670372009
TMs B-protein-family O 0.7505162954330444
at O O 0.9886974096298218
a O O 0.9889021515846252
concentration O O 0.9626353979110718
below O O 0.9819938540458679
2 O O 0.9690101146697998
μM O O 0.8551912903785706
fascin O O 0.7536176443099976
( O O 0.9760178327560425
closed O O 0.9692671895027161
circles) O O 0.7528194189071655
. O O 0.9812590479850769

Taking O O 0.9500194191932678
the O O 0.9920288920402527
results O O 0.9886140823364258
together O O 0.9880099892616272
, O O 0.9928096532821655
we O O 0.9934841990470886
conclude O O 0.9667497873306274
that O O 0.9931689500808716
DREF B-protein O 0.7083933353424072
binds O O 0.8763405084609985
to O O 0.9927505254745483
the O O 0.9898634552955627
DRE-related B-DNA O 0.7281850576400757
sequences I-DNA O 0.947333812713623
at O O 0.9880311489105225
540 O O 0.8236604928970337
to O O 0.9907388687133789
514 O O 0.6986388564109802
located O O 0.9513716101646423
upstream O O 0.9203945994377136
of O O 0.992790937423706
the O O 0.9915519952774048
initiation O O 0.9186918139457703
site O O 0.9671216607093811
of O O 0.9915739893913269
transcript-b O O 0.7302284240722656
. O O 0.9797347187995911

Interestingly O O 0.7687646150588989
, O O 0.9886448383331299
CKIepsilon B-protein O 0.7349705696105957
binds O O 0.8813892602920532
to O O 0.9916141033172607
mPER1 B-protein O 0.7595261931419373
in O O 0.9912794232368469
a O O 0.9888810515403748
region O O 0.9850420355796814
that O O 0.9950273633003235
has O O 0.9911110401153564
no O O 0.9914950132369995
obvious O O 0.9715617299079895
sequence O O 0.955033004283905
similarity O O 0.9596641659736633
to O O 0.9940630793571472
the O O 0.9922141432762146
suggested O O 0.9778317213058472
DBT-binding - O 0.7675418853759766
region O O 0.9831088185310364
of O O 0.9918741583824158
dPER B-protein O 0.7462626695632935
( O O 0.9701593518257141
27) O O 0.7412052750587463
. O O 0.9807552099227905

The O O 0.9746226072311401
ability O O 0.9826582074165344
of O O 0.9918345212936401
Emi1 B-protein O 0.7566994428634644
to O O 0.9915939569473267
inhibit O O 0.9398730993270874
an O O 0.9925230145454407
already O O 0.9806159734725952
activated O O 0.8782209157943726
APC B-protein O 0.7157858610153198
would O O 0.9917042255401611
be O O 0.9947233200073242
a O O 0.990198016166687
necessary O O 0.9897630214691162
feature O O 0.966712474822998
for O O 0.9918121099472046
Emi1 O O 0.7481204867362976
to O O 0.9887140393257141
inactivate O O 0.5727797746658325
Cdh1 B-protein B-protein 0.3386094868183136
already O O 0.9839297533035278
bound O O 0.9651795625686646
to O O 0.9939171671867371
the O O 0.9907451868057251
APC O O 0.7408078908920288
at O O 0.9895811080932617
the O O 0.9911338686943054
G1-S B-cell O 0.7661664485931396
transition O O 0.9619925618171692
. O O 0.982732892036438

Although O O 0.9670763611793518
the O O 0.9888101816177368
Hsp70 B-protein B-protein 0.44035622477531433
used O O 0.9864227175712585
contained O O 0.972250759601593
low O O 0.981134295463562
levels O O 0.9847004413604736
of O O 0.9903082251548767
endotoxin O B-protein 0.45953306555747986
( O O 0.9683988690376282
<0 O O 0.7597959637641907
. O O 0.9914980530738831
5 O O 0.9719544053077698
EU/mg O O 0.7871614694595337
as O O 0.992243230342865
assessed O O 0.9738339781761169
by O O 0.9938318729400635
the O O 0.9826779961585999
limulus O B-protein 0.18040359020233154
amebocyte O O 0.670465350151062
lysate O B-protein 0.1450119912624359
assay) O O 0.7971763610839844
, O O 0.9893372058868408
we O O 0.993286669254303
excluded O O 0.9670676589012146
a O O 0.9899284243583679
potential O O 0.9814524054527283
involvement O O 0.9635897874832153
of O O 0.9914602041244507
residual O O 0.8840351104736328
endotoxin O B-protein 0.4486134648323059
in O O 0.9861931204795837
Hsp70 O B-protein 0.3947540819644928
binding O O 0.9717589616775513
to O O 0.9914844632148743
APC B-protein O 0.7331407070159912
based O O 0.9850998520851135
on O O 0.9936622381210327
the O O 0.9935919642448425
following O O 0.9896770119667053
observations O O 0.9733138084411621
. O O 0.9837943911552429

 O O 0.4652291238307953
Additional O O 0.9751479625701904
evidence O O 0.990104615688324
that O O 0.9943708777427673
FKBP12 B-protein O 0.7612020373344421
specifically O O 0.9751793742179871
recognizes O O 0.930042028427124
the O O 0.9889729619026184
Leu-Pro B-protein-motif O 0.6990082263946533
motif I-protein-motif O 0.8360342383384705
is O O 0.9894518256187439
provided O O 0.9815529584884644
by O O 0.9941173791885376
previous O O 0.9846781492233276
reports O O 0.9828905463218689
( O O 0.9729698300361633
Okadome O O 0.7500854730606079
et O O 0.9376095533370972
al O O 0.969135046005249
. O O 0.9936490654945374
, O O 0.9929846525192261
1996 O O 0.9700058698654175
; O O 0.9898554086685181
Wang O O 0.9121178388595581
et O O 0.9448738694190979
al O O 0.9697181582450867
. O O 0.9932752847671509
, O O 0.9911143183708191
1996b O O 0.7598201036453247
) O O 0.977082371711731
and O O 0.9943969249725342
present O O 0.9886677861213684
observations O O 0.9730864763259888
that O O 0.9930632710456848
rapamycin B-drug B-protein 0.4968760907649994
and O O 0.989592432975769
FK506 B-chemical O 0.70848149061203
inhibit O O 0.9196935892105103
FKBP12 O O 0.7515934109687805
binding O O 0.9726178050041199
to O O 0.9928420782089233
TbetaR-I B-protein O 0.7425946593284607
. O O 0.9804290533065796

alpha-NAC B-protein O 0.3926141858100891
stabilizes O O 0.727262020111084
the O O 0.990760326385498
binding O O 0.9778192639350891
of O O 0.9933899641036987
the O O 0.9875262379646301
c-Jun B-protein-complex B-protein 0.3367823660373688
homodimer I-protein-complex O 0.6724257469177246
to O O 0.9911705255508423
the O O 0.9884284138679504
AP-1 B-protein-complex B-protein 0.41690003871917725
site O O 0.9541903734207153
. O O 0.9818843007087708

Binding O O 0.9201459288597107
of O O 0.9909759163856506
CRKL B-protein O 0.756844162940979
to O O 0.9907622933387756
Gab1 B-protein O 0.7472713589668274
is O O 0.9887507557868958
expected O O 0.9886177182197571
to O O 0.9939701557159424
lead O O 0.981575608253479
to O O 0.9937492609024048
an O O 0.9928584098815918
accumulation O O 0.9327347874641418
of O O 0.9904787540435791
C3G B-protein O 0.7311513423919678
near O O 0.970173716545105
the O O 0.9890668392181396
plasma O O 0.8490508794784546
membrane O O 0.9174068570137024
where O O 0.9874343276023865
it O O 0.9934032559394836
may O O 0.992188572883606
exert O O 0.953153669834137
its O O 0.9915870428085327
effect O O 0.9878950119018555
on O O 0.9918181896209717
Rap1 B-protein O 0.7374138832092285
. O O 0.9799743890762329

p23 B-protein B-protein 0.09504202008247375
and O O 0.9878580570220947
Hsp90 B-protein B-protein 0.2915748059749603
bind O O 0.8974846601486206
hTERT B-protein B-protein 0.26133912801742554
. O O 0.9743878245353699

Inhibin B-protein-complex B-protein 0.11835528910160065
also O O 0.9891510009765625
binds O O 0.8951305150985718
to O O 0.9921742677688599
ActRII B-protein O 0.761658787727356
through O O 0.9844660758972168
its O O 0.9886808395385742
beta B-protein-domain O 0.8379361629486084
subunit I-protein-domain O 0.6354694962501526
, O O 0.988200306892395
competes O O 0.8825073838233948
with O O 0.9929556846618652
the O O 0.992133617401123
binding O O 0.9724025130271912
of O O 0.9893428087234497
activin B-protein-complex B-protein 0.3804721534252167
to O O 0.9924192428588867
ActRII O O 0.7331316471099854
, O O 0.9901386499404907
but O O 0.9937798380851746
fails O O 0.9553240537643433
to O O 0.9938820600509644
form O O 0.9874621033668518
the O O 0.9903287291526794
ActRII B-protein-complex O 0.6977746486663818
SKR2 I-protein-complex O 0.7202772498130798
complex O O 0.970983624458313
. O O 0.9833658337593079

Although O O 0.9665310382843018
multiple O O 0.9774938821792603
transcription O O 0.894984781742096
factors O O 0.9859144687652588
bind O O 0.9509773254394531
to O O 0.9916597008705139
CBP B-protein O 0.6534889340400696
, O O 0.9897648096084595
there O O 0.9924709796905518
is O O 0.9909688830375671
a O O 0.9891380667686462
striking O O 0.9733762145042419
difference O O 0.9780899286270142
in O O 0.993368923664093
the O O 0.9926708936691284
role O O 0.9821420907974243
of O O 0.9912540316581726
CBP O O 0.662739098072052
depending O O 0.9838573932647705
on O O 0.9932754039764404
the O O 0.9905920624732971
transcriptional O O 0.7246055603027344
activator O O 0.6018431186676025
. O O 0.9775436520576477

 O O 0.4733903706073761
Several O O 0.9872936010360718
individual O O 0.9851271510124207
amino O O 0.9427751898765564
acid O O 0.946748673915863
residues O O 0.9377691149711609
in O O 0.9904934763908386
Shc B-protein B-protein 0.4884045422077179
have O O 0.9923282265663147
been O O 0.9922878742218018
implicated O O 0.9486089944839478
by O O 0.9890745282173157
site-directed O B-protein 0.3374135494232178
mutagenesis O O 0.7243357300758362
to O O 0.9915574789047241
be O O 0.9945571422576904
critical O O 0.9814198017120361
for O O 0.9903762936592102
Shc O B-protein 0.432548463344574
binding O O 0.9743916392326355
to O O 0.9935235977172852
the O O 0.9893836379051208
psi B-protein-motif O 0.6288729906082153
XNP I-protein-motif O 0.6198564171791077
XpY I-protein-motif O 0.6459985971450806
motif I-protein-motif O 0.8264995217323303
( O O 0.9765278100967407
17 O O 0.9766350984573364
, O O 0.9935230016708374
19 O O 0.9749341011047363
, O O 0.9919220209121704
20) O O 0.7583657503128052
. O O 0.981338620185852

It O O 0.9793709516525269
has O O 0.991166889667511
been O O 0.9933098554611206
reported O O 0.9837358593940735
that O O 0.99442058801651
ligands O O 0.8779564499855042
( O O 0.9727869033813477
e O O 0.8904299736022949
. O O 0.9912753105163574
g O O 0.8690336346626282
. O O 0.9908890128135681
echistatin B-protein O 0.751183807849884
) O O 0.9754437208175659
or O O 0.9909518957138062
RGD-containing - O 0.7167638540267944
peptides O O 0.8690725564956665
block O O 0.9458887577056885
binding O O 0.9745937585830688
of O O 0.9932053089141846
an O O 0.9916041493415833
RGD-containing B-reagent O 0.6776789426803589
anti-β3 I-reagent O 0.6622936725616455
antibody I-reagent O 0.8255895376205444
, O O 0.9895604848861694
16N7C2 B-reagent O 0.7823890447616577
, O O 0.9915719032287598
to O O 0.9924548864364624
β3 B-protein O 0.6763617396354675
integrin I-protein O 0.551429033279419
( O O 0.9659603238105774
19) O O 0.7412264347076416
. O O 0.9810031652450562

In O O 0.9776774048805237
fact O O 0.9870317578315735
, O O 0.9927120208740234
an O O 0.9936845898628235
analogous O O 0.9574649333953857
situation O O 0.987407922744751
has O O 0.9909239411354065
also O O 0.9909588098526001
been O O 0.9927420616149902
described O O 0.9821031093597412
that O O 0.9951854348182678
a O O 0.9885398745536804
residual O O 0.9240700602531433
binding O O 0.9724578261375427
of O O 0.9914306998252869
p130Cas B-protein O 0.7375298738479614
to O O 0.9871715903282166
FAK B-protein B-protein 0.3064107298851013
P712/715A O O 0.7630805373191833
mutant O O 0.826082706451416
possibly O O 0.9774258732795715
mediated O O 0.9553748965263367
by O O 0.9939279556274414
a O O 0.9893277287483215
second O O 0.9744865298271179
proline-rich - B-protein 0.375923752784729
region O O 0.9843109250068665
( O O 0.9730928540229797
amino O O 0.9387329816818237
acids O O 0.9594765901565552
875-884 O O 0.7629168629646301
) O O 0.9762701392173767
on O O 0.9902929067611694
FAK O B-protein 0.47604215145111084
does O O 0.9849407076835632
not O O 0.9946152567863464
allow O O 0.9884523749351501
for O O 0.9923856258392334
FAK-promoted O O 0.7607241868972778
migration O O 0.965634286403656
( O O 0.9738758206367493
22) O O 0.748956024646759
. O O 0.9809964895248413

 O O 0.46540650725364685
Therefore O O 0.9828851222991943
, O O 0.9915609955787659
deactivation O O 0.7983508706092834
of O O 0.9904223680496216
CF1 B-protein-complex O 0.7460722923278809
in O O 0.9895331263542175
vivo O O 0.846199095249176
probably O O 0.9774567484855652
involves O O 0.9736758470535278
an O O 0.993180513381958
alternative O O 0.9702999591827393
form O O 0.9860314130783081
of O O 0.9927103519439697
regulation O O 0.9696223139762878
such O O 0.993180513381958
as O O 0.992588996887207
the O O 0.9918930530548096
binding O O 0.9721906185150146
of O O 0.9917483329772949
ADP B-chemical O 0.8770329356193542
to O O 0.992461621761322
the O O 0.9894649982452393
β-subunit B-protein O 0.7400543689727783
, O O 0.9898356795310974
which O O 0.9928761720657349
has O O 0.9909407496452332
previously O O 0.9803062677383423
been O O 0.9927911758422852
shown O O 0.9851299524307251
to O O 0.9920622110366821
deactivate O O 0.6496041417121887
CF1 O O 0.6764828562736511
enzymatic O O 0.8852637410163879
activity O O 0.9830816388130188
in O O 0.9938225746154785
the O O 0.9931393265724182
dark O O 0.9703322649002075
( O O 0.9741577506065369
16) O O 0.7443088889122009
. O O 0.98064786195755

p53 B-protein O 0.4662005305290222
specifically O O 0.9680164456367493
binds O O 0.9037927985191345
to O O 0.9937386512756348
its O O 0.9917260408401489
consensus O O 0.9757609367370605
DNA B-DNA O 0.9596592783927917
binding O O 0.9697988629341125
sequence O O 0.9560990929603577
, O O 0.9914541244506836
consisting O O 0.9593939781188965
of O O 0.9932622313499451
two O O 0.9918308854103088
repeats O O 0.9124182462692261
of O O 0.9900043606758118
10-bp O O 0.6714426279067993
motif O O 0.7868139743804932
5-PuPuPuC B-DNA O 0.7000749707221985
( I-DNA O 0.9675199389457703
A/T)(T/A)GPyPyPy-3(2) I-DNA O 0.7723535299301147
, O O 0.9909396171569824
and O O 0.9929056167602539
transactivates O O 0.7628940343856812
expression O O 0.9737507700920105
of O O 0.993535041809082
the O O 0.9925272464752197
target O O 0.9723410606384277
genes O O 0.9690834283828735
. O O 0.9836148619651794

Furthermore O O 0.9160894155502319
, O O 0.9924798011779785
when O O 0.9922261238098145
the O O 0.991309642791748
C-terminal O O 0.7442210912704468
194 O O 0.8524891138076782
residues O O 0.9303745627403259
were O O 0.9928669929504395
deleted O O 0.876348614692688
, O O 0.9901121258735657
E6TP1 B-protein O 0.7768255472183228
could O O 0.9915339350700378
not O O 0.994387686252594
bind O O 0.9568206071853638
to O O 0.992403507232666
E6 B-protein O 0.7049339413642883
. O O 0.9789299368858337

GI B-protein-domain B-protein 0.2534852921962738
domain-binding O O 0.724592387676239
region O O 0.9817731976509094
of O O 0.9926126003265381
GCN1 B-protein O 0.7862441539764404
and O O 0.993021547794342
mutations O O 0.960928201675415
abolishing O O 0.9291306734085083
interaction O O 0.9732221961021423
. O O 0.9840595722198486

Comparison O O 0.9106722474098206
of O O 0.9926048517227173
the O O 0.9908657670021057
Ral-binding - O 0.7568093538284302
surface O O 0.9807611703872681
of O O 0.991295337677002
Sec5 B-protein O 0.7585337162017822
with O O 0.992146909236908
the O O 0.9921033978462219
region O O 0.9840752482414246
of O O 0.9907235503196716
GDI B-protein O 0.5764631628990173
that O O 0.9914534091949463
interacts O O 0.8547333478927612
with O O 0.9887111186981201
Rho B-protein-family B-protein 0.4857771098613739
family I-protein-family O 0.9598515033721924
G I-protein-family O 0.8380821943283081
proteins I-protein-family O 0.9598681330680847
shows O O 0.9807089567184448
that O O 0.9952098727226257
the O O 0.9924862384796143
contacts O O 0.9688462615013123
between O O 0.990628182888031
Sec5-Ral O O 0.7513290047645569
and O O 0.9912393689155579
GDI-Cdc42 - O 0.7708971500396729
are O O 0.9940019249916077
significantly O O 0.9837698936462402
different O O 0.992649495601654
. O O 0.9849409461021423

In O O 0.978413462638855
this O O 0.993878960609436
study O O 0.9885641932487488
, O O 0.9928707480430603
I O O 0.9872781038284302
examined O O 0.9660030007362366
the O O 0.9893603324890137
Rab B-protein-family O 0.5308700799942017
binding O O 0.9651294350624084
activities O O 0.9852604269981384
of O O 0.9917343854904175
Rim1 B-protein O 0.7469456791877747
, O O 0.9884218573570251
Rim2 B-protein O 0.7483710050582886
, O O 0.9888172149658203
Noc2 B-protein O 0.7683348655700684
, O O 0.9910174608230591
and O O 0.9931135773658752
rabphilin B-protein O 0.7652909755706787
by O O 0.9900450110435486
cotransfection O O 0.7072398662567139
assay O O 0.8220908641815186
in O O 0.9895791411399841
COS-7 B-cell O 0.7469431757926941
cells O O 0.9746341705322266
using O O 0.9853766560554504
42 O O 0.9455998539924622
different O O 0.9888823628425598
Rab O O 0.5146308541297913
proteins O O 0.9505778551101685
( O O 0.9778954386711121
including O O 0.9900110363960266
37 O O 0.9424678087234497
subfamilies O O 0.9078029990196228
reported O O 0.9820029735565186
in O O 0.9933214783668518
the O O 0.9913516044616699
mouse O O 0.87293541431427
data O O 0.9803751111030579
bases O O 0.9665048718452454
( O O 0.9768731594085693
18 O O 0.9820224046707153
, O O 0.9920231103897095
19 O O 0.9664235711097717
) O O 0.9779115319252014
) O O 0.9802231788635254
and O O 0.9943998456001282
found O O 0.9881625771522522
that O O 0.9953650236129761
these O O 0.9940392971038818
molecules O O 0.9681921005249023
exhibit O O 0.9544839262962341
distinct O O 0.9734025597572327
Rab O O 0.5429881811141968
binding O O 0.9667301774024963
specificity O O 0.9425796270370483
. O O 0.9831454753875732

For O O 0.9670706987380981
Gsb B-protein B-protein 0.378185898065567
might O O 0.9844436645507812
be O O 0.994443953037262
able O O 0.9848271608352661
to O O 0.9940910935401917
recognize O O 0.9750626087188721
some O O 0.9900093674659729
Ey B-protein B-protein 0.42173489928245544
binding O O 0.9715772867202759
sites O O 0.9736180305480957
even O O 0.9916531443595886
in O O 0.9933807849884033
the O O 0.9925221800804138
absence O O 0.9746648669242859
of O O 0.9923228025436401
its O O 0.9871533513069153
homeodomain O B-protein 0.4156336784362793
, O O 0.9917845726013184
and O O 0.9934272766113281
binding O O 0.9728225469589233
of O O 0.9892280101776123
Gsb O B-protein 0.3647381365299225
to O O 0.991384744644165
Ey O B-protein 0.4177941381931305
might O O 0.9866765737533569
depend O O 0.9816004037857056
on O O 0.9932507872581482
both O O 0.9926843047142029
its O O 0.9909477829933167
paired O O 0.913229763507843
domain O O 0.924299955368042
and O O 0.9923771619796753
C-terminal O O 0.774753749370575
portion O O 0.9445540308952332
. O O 0.9819505214691162

( O O 0.9168720245361328
B O O 0.8758761286735535
) O O 0.9787966012954712
Binding O O 0.9776565432548523
of O O 0.9933176040649414
a O O 0.9863752722740173
NES B-protein-motif O 0.6594394445419312
to O O 0.9902368187904358
CRM1 B-protein O 0.7455231547355652
occurs O O 0.9830232262611389
in O O 0.9931727051734924
a O O 0.9887816309928894
tripartite O O 0.8581599593162537
complex O O 0.975980281829834
with O O 0.9923586249351501
RanGTP B-protein O 0.7457746863365173
. O O 0.9805957078933716

Note O O 0.8928642868995667
that O O 0.9947565793991089
the O O 0.9915225505828857
LRR-to-EEE O O 0.7551860809326172
conversion O O 0.9515239000320435
altered O O 0.967648983001709
the O O 0.98995041847229
Rab B-protein-family O 0.5414382815361023
binding O O 0.9659721851348877
specificity O O 0.9480660557746887
of O O 0.9917004704475403
Rim2 B-protein O 0.735727071762085
. O O 0.9800885319709778

c) O O 0.464740514755249
, O O 0.9889674782752991
the O O 0.9927634596824646
effect O O 0.9885151982307434
of O O 0.9938522577285767
different O O 0.9924246072769165
amounts O O 0.9790003895759583
of O O 0.9909347891807556
D315A O O 0.6754021048545837
procaspase-9 B-protein O 0.6814148426055908
( O O 0.9665603637695312
DA B-protein O 0.8053649663925171
. I-protein O 0.9904768466949463
Caspase-9 I-protein O 0.7564675807952881
) O O 0.9766294360160828
on O O 0.9916137456893921
dATP B-chemical O 0.7651140093803406
binding O O 0.971106231212616
to O O 0.9927678108215332
Apaf-1 B-protein O 0.7776330709457397
was O O 0.9887081384658813
measured O O 0.9792090654373169
. O O 0.9847107529640198

In O O 0.9785522818565369
the O O 0.9921695590019226
presence O O 0.9809627532958984
of O O 0.9931228756904602
the O O 0.9896339178085327
fibronectin-like - O 0.7051358222961426
domain O O 0.9036359786987305
, O O 0.9902772903442383
which O O 0.9914796352386475
binds O O 0.8798466324806213
tightly O O 0.9512122869491577
to O O 0.9933720827102661
both O O 0.9905534386634827
collagen B-protein-family O 0.8365136384963989
and O O 0.9911587834358215
gelatin B-protein-family O 0.7719144225120544
[ O O 0.9165491461753845
15] O O 0.7481200695037842
, O O 0.9894940257072449
[ O O 0.9289464950561523
16] O O 0.756857693195343
, O O 0.9894970655441284
[ O O 0.9282350540161133
19] O O 0.7633517980575562
, O O 0.99094557762146
further O O 0.9908581376075745
breakdown O O 0.9548285603523254
of O O 0.9928694367408752
the O O 0.9907942414283752
1/4 O O 0.880901575088501
and O O 0.9912835359573364
3/4 O O 0.8477867245674133
fragments O O 0.9436966180801392
occurs O O 0.9846370220184326
, O O 0.992562472820282
even O O 0.9919369220733643
at O O 0.9887052178382874
25°C O O 0.7558413743972778
, O O 0.9902847409248352
which O O 0.9930402040481567
is O O 0.9911980032920837
generally O O 0.9902403354644775
regarded O O 0.9724727272987366
as O O 0.9930236339569092
insufficient O O 0.9731272459030151
to O O 0.9926086068153381
denature O O 0.6871935725212097
the O O 0.9888012409210205
3/4 O O 0.847590446472168
fragment O O 0.8870421648025513
. O O 0.9817999601364136

Whereas O O 0.8835384249687195
FK506 B-chemical O 0.7045775055885315
stimulates O O 0.8570303320884705
the O O 0.9912620782852173
binding O O 0.9755613207817078
of O O 0.9918524622917175
FKBP12 B-protein O 0.7454003691673279
to O O 0.9889143109321594
calcineurin B-protein B-protein 0.4341897666454315
( O O 0.969929039478302
42) O O 0.7568276524543762
, O O 0.9895804524421692
stoichiometric O O 0.8271280527114868
quantities O O 0.9687883853912354
of O O 0.9912238121032715
FK506 O O 0.6904579401016235
dissociate O O 0.74500572681427
FKBP12 O O 0.7371953725814819
from O O 0.9895498752593994
the O O 0.988562822341919
ryanodine B-protein-family B-protein 0.37941181659698486
and O O 0.989986002445221
IP3 B-protein-family B-protein 0.33181774616241455
receptors I-protein-family O 0.9290598630905151
( O O 0.9769933819770813
11 O O 0.982001543045044
, O O 0.991883397102356
36) O O 0.7592278122901917
. O O 0.981357991695404

The O O 0.9742583632469177
function O O 0.9809347987174988
of O O 0.9931766986846924
the O O 0.9877574443817139
GUK B-protein-domain B-protein 0.3309091329574585
domain I-protein-domain O 0.9355406165122986
, O O 0.990254819393158
which O O 0.9918743968009949
lacks O O 0.9230810403823853
kinase O O 0.6436640024185181
activity O O 0.9790431261062622
in O O 0.9923833012580872
the O O 0.9898556470870972
MAGUK B-protein-family O 0.7102612853050232
proteins I-protein-family O 0.9511378407478333
analyzed O O 0.9562720656394958
so O O 0.9918527007102966
far O O 0.988277018070221
, O O 0.9920371770858765
is O O 0.9908389449119568
not O O 0.9942671656608582
known O O 0.9842624664306641
but O O 0.993902325630188
has O O 0.990871250629425
been O O 0.9923813939094543
suggested O O 0.9818131923675537
to O O 0.9940650463104248
be O O 0.9947152733802795
important O O 0.9899197816848755
for O O 0.9933713674545288
binding O O 0.9742727279663086
of O O 0.9916644096374512
ZO-1 B-protein O 0.7525398135185242
to O O 0.9908662438392639
occludin B-protein O 0.7319848537445068
( O O 0.9692099690437317
5) O O 0.739076554775238
. O O 0.9806508421897888

To O O 0.9805672764778137
test O O 0.9764629602432251
whether O O 0.9890025854110718
Bet B-protein O 0.8654369115829468
v I-protein O 0.8512388467788696
1 I-protein O 0.9738320708274841
can O O 0.990637481212616
bind O O 0.9289979338645935
amphiphilic O B-protein 0.4889286160469055
molecules O O 0.9568955898284912
in O O 0.9925898313522339
general O O 0.9833705425262451
, O O 0.9924911856651306
we O O 0.9934966564178467
also O O 0.9910469651222229
examined O O 0.9669445157051086
binding O O 0.9753093123435974
of O O 0.992117702960968
bis-ANS B-reagent O 0.7655394673347473
and O O 0.9912433624267578
SDS B-reagent O 0.7015004754066467
. O O 0.9799839854240417

Because O O 0.9714643359184265
Sec15p B-protein O 0.7475140690803528
also O O 0.9872079491615295
binds O O 0.8987659811973572
to O O 0.9921504259109497
activated O O 0.8864772915840149
Sec4p B-protein O 0.7474938035011292
, O O 0.9903113842010498
the O O 0.9905097484588623
exocyst O O 0.7601801156997681
might O O 0.9865747094154358
be O O 0.9942569136619568
an O O 0.991936445236206
effector O O 0.606228232383728
for O O 0.9903225302696228
this O O 0.9902044534683228
Rab-like B-protein-family O 0.639555037021637
GTPase I-protein-family B-protein 0.39342883229255676
that O O 0.9935994148254395
is O O 0.9905393123626709
necessary O O 0.9901429414749146
for O O 0.9938997030258179
the O O 0.9924367070198059
targeting O O 0.9616175293922424
or O O 0.9902527332305908
tethering O O 0.6097373962402344
of O O 0.9856513738632202
secretory O B-protein 0.4463953971862793
vesicles O O 0.7371504306793213
to O O 0.9920837879180908
sites O O 0.9772142171859741
of O O 0.9924119114875793
secretion O O 0.8814424872398376
. O O 0.9814150929450989

From O O 0.9739829301834106
these O O 0.9941058158874512
results O O 0.9890154004096985
we O O 0.9934358596801758
conclude O O 0.9689667820930481
that O O 0.9950394034385681
the O O 0.992133617401123
binding O O 0.9723110795021057
of O O 0.9900414347648621
p300 B-protein O 0.5278258919715881
and O O 0.9896088242530823
SAF-A B-protein O 0.755035936832428
to O O 0.991970419883728
the O O 0.9860976934432983
MII B-DNA B-protein 0.28646954894065857
S/MAR I-DNA O 0.7892948389053345
element I-DNA O 0.9461283683776855
, O O 0.991990864276886
as O O 0.9933949112892151
observed O O 0.9835547804832458
in O O 0.9924387335777283
U-2 B-cell O 0.8251481056213379
OS I-cell O 0.814188539981842
and O O 0.9908095598220825
VH10 B-cell O 0.7418228387832642
cells O O 0.9749098420143127
, O O 0.9921914935112
is O O 0.991374671459198
absent O O 0.9613869786262512
in O O 0.9919033646583557
SV40- B-cell O 0.771194338798523
and O O 0.9916471242904663
adenovirus-transformed B-cell O 0.7564520835876465
cells I-cell O 0.9747342467308044
. O O 0.9834475517272949

Karyopherin B-protein O 0.37542402744293213
beta2 I-protein O 0.6329069137573242
( O O 0.968949556350708
Kapbeta2 B-protein O 0.7780716419219971
, O O 0.989662766456604
transportin B-protein O 0.7563908696174622
) O O 0.9738646149635315
binds O O 0.897369921207428
the O O 0.9878079295158386
M9 B-protein-motif B-protein 0.42092278599739075
sequence O O 0.9559390544891357
of O O 0.9916688203811646
human O O 0.9819177985191345
ribonucleoprotein B-protein B-protein 0.27594006061553955
A1 I-protein O 0.7906200885772705
and O O 0.9905866980552673
mediates O O 0.8571498990058899
its O O 0.9910741448402405
nuclear O O 0.9819329380989075
import O O 0.966799259185791
. O O 0.9834164381027222

poly( B-chemical O 0.38463807106018066
dC)-agarose I-chemical O 0.6597804427146912
; O O 0.9869590401649475
lane O O 0.9212387800216675
3 O O 0.9756415486335754
, O O 0.9902310967445374
DADA B-mutation O 0.6645100116729736
mutant O O 0.8245930075645447
protein O O 0.9450274705886841
bound O O 0.9687406420707703
to O O 0.9926804900169373
poly( B-chemical O 0.7029615044593811
dI) I-chemical O 0.7025935053825378
. O O 0.9793784022331238

Binding O O 0.9200564026832581
of O O 0.9899896383285522
NF1 B-protein B-protein 0.4508395195007324
to O O 0.9910904169082642
the O O 0.989788293838501
Sp1-mutated - O 0.7232677340507507
labeled O O 0.9111647009849548
probe O O 0.9289326071739197
was O O 0.9884448051452637
monitored O O 0.9663721323013306
by O O 0.9913058876991272
EMSA B-assay B-protein 0.48835116624832153
as O O 0.9906508922576904
in O O 0.9924774765968323
Fig O O 0.8896709680557251
. O O 0.9932072758674622
2 O O 0.9748407602310181
. O O 0.9844220876693726

 O O 0.461370050907135
This O O 0.9903220534324646
suggests O O 0.9770370721817017
that O O 0.9952647686004639
, O O 0.9929896593093872
even O O 0.9926859140396118
in O O 0.9937454462051392
the O O 0.9927793145179749
absence O O 0.9747544527053833
of O O 0.9912573099136353
Ca2+ B-chemical O 0.7299534678459167
, O O 0.9862666130065918
CEB B-protein B-protein 0.42688873410224915
does O O 0.9863941073417664
not O O 0.9937773942947388
bind O O 0.9425519704818726
GTP B-chemical O 0.6977490782737732
. O O 0.9797729253768921

Swinholide B-chemical O 0.4376092553138733
A I-chemical O 0.9761252999305725
sequesters O B-protein 0.38903719186782837
G-actin - O 0.7118307948112488
as O O 0.9887669682502747
dimers O O 0.7704334259033203
and O O 0.9930693507194519
can O O 0.9909181594848633
sever O O 0.8345189690589905
F-actin B-protein B-protein 0.46244096755981445
( O O 0.9720680713653564
10 O O 0.984024167060852
, O O 0.9931637644767761
24 O O 0.9801571369171143
, O O 0.9915398955345154
37) O O 0.7576982378959656
; O O 0.9822742342948914
cytochalasin B-chemical B-protein 0.33992624282836914
D I-chemical O 0.8770952224731445
induces O O 0.835043728351593
dimerization O O 0.640941858291626
of O O 0.9892570376396179
G-actin O O 0.7536898255348206
, O O 0.989513099193573
promotes O O 0.9214538335800171
ATP B-chemical O 0.7846733927726746
hydrolysis O O 0.8726710677146912
, O O 0.9916642904281616
and O O 0.9936979413032532
caps O O 0.9304601550102234
filament O O 0.7486007213592529
barbed O O 0.8903481364250183
ends O O 0.9578601717948914
( O O 0.9762403964996338
see O O 0.9784573912620544
Sampath O O 0.5427201986312866
and O O 0.989343523979187
Pollard O O 0.7605322599411011
1991) O O 0.7325233817100525
; O O 0.9882405996322632
and O O 0.9941818118095398
binding O O 0.9759396314620972
of O O 0.9918932914733887
profilin B-protein-family O 0.7504163980484009
to O O 0.990432858467102
actin O O 0.7529513835906982
promotes O O 0.9101076722145081
nucleotide O O 0.8338634371757507
exchange O O 0.9761390686035156
( O O 0.9709088802337646
Schluter O O 0.48253917694091797
et O O 0.9366021752357483
al O O 0.9723796248435974
. O O 0.9928951859474182
1997) O O 0.7643195390701294
. O O 0.981709897518158

TnI B-protein-family O 0.5312893390655518
, O O 0.9897357225418091
the O O 0.9907470941543579
inhibitory O O 0.8087203502655029
subunit O O 0.6534665822982788
, O O 0.9887252449989319
inhibits O O 0.8791255354881287
the O O 0.987890362739563
actomyosin B-protein O 0.6344698071479797
ATPase I-protein B-protein 0.3633343279361725
and O O 0.9913808703422546
binds O O 0.8671184778213501
actin B-protein O 0.7981148958206177
, O O 0.9913471341133118
while O O 0.9896440505981445
TnT B-protein-family O 0.7410869598388672
binds O O 0.807267963886261
tropomyosin B-protein-family B-protein 0.2803352475166321
. O O 0.9790171980857849

As O O 0.9765052795410156
shown O O 0.9846485257148743
in O O 0.9932923316955566
Figure O O 0.9729201197624207
7 O O 0.9700279831886292
, O O 0.992685079574585
while O O 0.9919012188911438
both O O 0.9906230568885803
TR B-protein O 0.6540250182151794
and O O 0.9907399415969849
v-ErbA B-protein O 0.7489521503448486
can O O 0.9896746277809143
bind O O 0.9486208558082581
to O O 0.9904438853263855
TBP B-protein B-protein 0.4026854932308197
, O O 0.9901534914970398
v-ErbA O O 0.7411044239997864
is O O 0.9876174330711365
moderately O O 0.9378792643547058
impaired O O 0.9448630809783936
in O O 0.9926806092262268
direct O O 0.9800602197647095
binding O O 0.9729362726211548
to O O 0.9923496842384338
TFIIB B-protein-complex O 0.7580665946006775
in O O 0.9915053248405457
an O O 0.9935616254806519
in O O 0.9924818873405457
vitro O O 0.9378811717033386
( O O 0.9735040068626404
Figure O O 0.9562793970108032
6B O B-protein 0.36688193678855896
) O O 0.9815873503684998
and O O 0.9943045973777771
an O O 0.9943040013313293
in O O 0.9923927783966064
vivo O O 0.8397740721702576
assay O O 0.8428126573562622
( O O 0.9765735864639282
Figure O O 0.969347357749939
7C) O O 0.7521940469741821
. O O 0.9812378287315369

 O O 0.4507324695587158
Binding O O 0.963783323764801
of O O 0.9904878735542297
PIP2 B-chemical B-protein 0.4573442339897156
to O O 0.9893673062324524
vinculin B-protein O 0.7119285464286804
unfolds O O 0.8690375089645386
the O O 0.9894171357154846
inactive O O 0.8930644392967224
molecule O O 0.9066160321235657
and O O 0.992661714553833
exposes O O 0.8605372905731201
binding O O 0.9710888266563416
sites O O 0.9746375679969788
for O O 0.9902573823928833
talin B-protein B-protein 0.4529454708099365
and O O 0.9913538098335266
alpha-actinin B-protein-family O 0.7528471350669861
in O O 0.991439938545227
the O O 0.9916398525238037
head O O 0.9674654006958008
domain O O 0.9230061173439026
and O O 0.9932255148887634
for O O 0.9909163117408752
VASP B-protein O 0.5329453945159912
in O O 0.9903636574745178
the O O 0.990865170955658
tail O O 0.9222670197486877
domain O O 0.9131522178649902
( O O 0.9709957242012024
Gilmore O O 0.7415065765380859
and O O 0.9908305406570435
Burridge O O 0.6522505283355713
, O O 0.990558385848999
1996 O O 0.9688509702682495
; O O 0.989096462726593
Huttelmaier O O 0.7697287201881409
et O O 0.9437026977539062
al O O 0.9725322723388672
. O O 0.99420565366745
, O O 0.992212176322937
1999) O O 0.7598133087158203
. O O 0.9813370108604431

 O O 0.46762561798095703
While O O 0.9878103733062744
the O O 0.9926397800445557
region O O 0.9853487610816956
of O O 0.9918288588523865
Apaf-1 B-protein O 0.7554283738136292
that O O 0.9934265613555908
is O O 0.9903077483177185
involved O O 0.9858368635177612
in O O 0.9926996827125549
binding O O 0.9715198874473572
with O O 0.989777147769928
Hsp90 B-protein-family B-protein 0.43617480993270874
is O O 0.9895641803741455
not O O 0.9938192963600159
known O O 0.9847804307937622
, O O 0.9927378296852112
our O O 0.9899718761444092
results O O 0.9878790974617004
demonstrate O O 0.9747825264930725
that O O 0.991610586643219
Hsp90 O B-protein 0.3577158749103546
binds O O 0.9062684178352356
to O O 0.9904877543449402
Apaf-1 O O 0.7486307621002197
at O O 0.9881964325904846
a O O 0.9888456463813782
different O O 0.9921829104423523
site O O 0.968904972076416
than O O 0.9934345483779907
that O O 0.9948729872703552
of O O 0.9883495569229126
cyt B-protein B-protein 0.2372281700372696
c I-protein O 0.9285520315170288
( O O 0.9751697182655334
data O O 0.9853781461715698
not O O 0.9938259124755859
shown) O O 0.75090491771698
. O O 0.9807283282279968

They O O 0.9831076860427856
considered O O 0.9876434803009033
whether O O 0.9914474487304688
this O O 0.9942420125007629
result O O 0.9905484318733215
might O O 0.9894192218780518
be O O 0.9947172999382019
explained O O 0.9725120663642883
if O O 0.9926044940948486
both O O 0.9884004592895508
kinesin B-protein-complex B-protein 0.35849159955978394
II I-protein-complex O 0.9496427178382874
and O O 0.9893466830253601
dynein B-protein-family B-protein 0.3983471691608429
bound O O 0.9638045430183411
to O O 0.9918652176856995
dynactin B-protein-complex O 0.7650004029273987
and O O 0.9925467371940613
thereby O O 0.9685382843017578
docked O O 0.8818689584732056
onto O O 0.9526956677436829
membranes O O 0.9360789656639099
. O O 0.9827006459236145

Within O O 0.9654273390769958
the O O 0.9906909465789795
ATP B-chemical O 0.8235549330711365
binding O O 0.9711146950721741
site O O 0.9658657908439636
of O O 0.9893953204154968
PKM B-protein B-protein 0.33052125573158264
, O O 0.9908931255340576
lysine B-amino-acid O 0.7299890518188477
221 O O 0.8257136940956116
was O O 0.9882203340530396
changed O O 0.9806807637214661
to O O 0.9925642609596252
tryptophan B-amino-acid O 0.7309384942054749
( O O 0.9671251773834229
K221W B-mutation O 0.7421696782112122
) O O 0.9752042889595032
corresponding O O 0.9702985882759094
to O O 0.9940329194068909
a O O 0.9885401129722595
mutation O O 0.9446921348571777
in O O 0.9915715456008911
Raf-1 B-protein O 0.7730869054794312
that O O 0.9938031435012817
abolished O O 0.9598847031593323
its O O 0.9888784289360046
kinase O O 0.6650142669677734
activity O O 0.9796660542488098
( O O 0.9740526676177979
41) O O 0.7483873963356018
. O O 0.980882465839386

U2AF B-protein-family O 0.4454280734062195
bound O O 0.953679084777832
to O O 0.9937061667442322
the O O 0.9884824156761169
PY B-DNA B-protein 0.3290371596813202
tract I-DNA O 0.9404752850532532
and O O 0.9922246932983398
AG B-DNA O 0.8728527426719666
within O O 0.9838694930076599
exon O O 0.6511162519454956
3 O O 0.9661523103713989
recruits O O 0.881892204284668
U2 B-protein-RNA-complex O 0.6476382613182068
snRNP O B-protein 0.30603572726249695
to O O 0.9933985471725464
the O O 0.9886881709098816
BPS B-DNA O 0.464738667011261
. O O 0.9764975309371948

The O O 0.9663838744163513
amphiphysin B-protein-family O 0.675689697265625
dimer O O 0.6956822276115417
also O O 0.9864714741706848
binds O O 0.8920990228652954
to O O 0.989866316318512
clathrin B-protein-complex B-protein 0.35787686705589294
( O O 0.9788378477096558
10 O O 0.9821586012840271
, O O 0.9923192858695984
11 O O 0.9792560338973999
) O O 0.9810288548469543
and O O 0.9947603344917297
to O O 0.9943928718566895
the O O 0.9897575378417969
α-adaptin B-protein O 0.6714521646499634
subunit O O 0.6438621282577515
of O O 0.990980327129364
the O O 0.9898756146430969
plasma O O 0.8319147825241089
membrane O O 0.8378378748893738
clathrin O B-protein 0.1692279577255249
adaptor O O 0.5183473229408264
AP-2 B-protein-complex B-protein 0.2533971667289734
( O O 0.975177526473999
9 O O 0.9654804468154907
, O O 0.9925324320793152
12 O O 0.9793218970298767
) O O 0.981433093547821
and O O 0.9946591258049011
thus O O 0.9887509942054749
may O O 0.9921191930770874
mediate O O 0.928260862827301
recruitment O O 0.9155519008636475
of O O 0.9902961850166321
dynamin B-protein O 0.7322719693183899
1 I-protein O 0.9717355370521545
and O O 0.9922336339950562
synaptojanin B-protein O 0.7542862296104431
1 I-protein O 0.9754515290260315
to O O 0.9943522214889526
the O O 0.9928026795387268
site O O 0.9694626331329346
of O O 0.991001546382904
clathrin-mediated O O 0.6727598905563354
endocytosis O O 0.6481091976165771
. O O 0.9776840209960938

The O O 0.9702872633934021
amplified O O 0.8926999568939209
DNA B-DNA O 0.9628039002418518
was O O 0.9891921877861023
isolated O O 0.971445620059967
, O O 0.9912841320037842
digested O O 0.8605453968048096
, O O 0.9914997220039368
and O O 0.9936109185218811
cloned O O 0.9282342791557312
into O O 0.9864800572395325
the O O 0.9852586984634399
T7 - B-protein 0.21740791201591492
RNA - O 0.8485324382781982
polymerase-based - O 0.7036074995994568
( O O 0.9730342626571655
30 O O 0.9811742305755615
) O O 0.9770480394363403
pCAL B-experimental-construct O 0.7577889561653137
bacterial O O 0.941115140914917
expression O O 0.9730229377746582
vector O O 0.9357179999351501
( O O 0.9728231430053711
Stratagene B-brand O 0.7642309069633484
) O O 0.9777255058288574
as O O 0.9930210709571838
a O O 0.9881594181060791
translational O O 0.8276229500770569
fusion O O 0.8944368362426758
to O O 0.9932204484939575
the O O 0.9890316128730774
calmodulin B-peptide O 0.49666279554367065
binding I-peptide O 0.9549328684806824
peptide I-peptide O 0.7866923809051514
( O O 0.9716526865959167
CBP) - O 0.7484878897666931
. O O 0.9810839295387268

This O O 0.9801182746887207
analysis O O 0.9835634231567383
revealed O O 0.9738006591796875
specific O O 0.9897673726081848
in O O 0.9922763705253601
vivo O O 0.8580145835876465
binding O O 0.9721397161483765
of O O 0.9917135238647461
NFAT5 B-protein O 0.7677306532859802
to O O 0.9924030303955078
the O O 0.9870813488960266
TNFα B-DNA B-protein 0.340032160282135
proximal I-DNA O 0.8718379735946655
promoter I-DNA O 0.7937846779823303
and O O 0.992350161075592
the O O 0.9854251742362976
aldose B-DNA B-protein 0.25470656156539917
reductase I-DNA O 0.4942132830619812
enhancer I-DNA O 0.6864078640937805
in O O 0.9909124374389648
response O O 0.9836745262145996
to O O 0.9915395379066467
hypertonic O O 0.5308725237846375
stimulation O O 0.9180411100387573
, O O 0.9909817576408386
either O O 0.9886118769645691
alone O O 0.9793413281440735
or O O 0.9933308959007263
in O O 0.9931894540786743
combination O O 0.9668282270431519
with O O 0.990849494934082
PMA B-chemical O 0.546619176864624
( O O 0.9668819904327393
Figure O O 0.9610311388969421
6D O O 0.6258180141448975
, O O 0.9900708794593811
right O O 0.9871922731399536
, O O 0.9925596714019775
top O O 0.9754863381385803
and O O 0.9939650893211365
middle O O 0.9743101596832275
panels O O 0.9555212259292603
, O O 0.9910979866981506
lanes O O 0.9224523305892944
5 O O 0.9756293892860413
and O O 0.9931922554969788
6) O O 0.7478569746017456
. O O 0.9807239770889282

Binding O O 0.9234064221382141
of O O 0.990078330039978
Numb B-protein O 0.7205216288566589
PTB B-protein-domain B-protein 0.3065967857837677
domain I-protein-domain O 0.931097149848938
to O O 0.9918387532234192
LNX B-protein O 0.739050567150116
. O O 0.980416476726532

The O O 0.9757583141326904
majority O O 0.9832924008369446
of O O 0.992093026638031
gp160 B-protein O 0.7566166520118713
remained O O 0.9760701060295105
bound O O 0.9647759199142456
to O O 0.9926294088363647
calreticulin B-protein O 0.7660265564918518
despite O O 0.9858288764953613
addition O O 0.9809780120849609
of O O 0.9921756386756897
ATP B-chemical O 0.8170223832130432
( O O 0.976534366607666
not O O 0.9935935139656067
shown) O O 0.7492745518684387
. O O 0.9807227253913879

Activation O O 0.8023937940597534
of O O 0.9889925122261047
p53 B-protein O 0.7007485032081604
Sequence-Specific O O 0.4793526530265808
DNA B-DNA O 0.9500002861022949
Binding O O 0.9740297198295593
by O O 0.992676317691803
Acetylation O O 0.7844460606575012
of O O 0.9923166036605835
the O O 0.9897699356079102
p53 O O 0.7195367217063904
C-Terminal O O 0.7289133071899414
Domain O O 0.9098541736602783
. O O 0.9816704988479614

In O O 0.9773238301277161
contrast O O 0.9799798727035522
to O O 0.9943642616271973
their O O 0.9938167929649353
effects O O 0.9826371073722839
on O O 0.9918738007545471
cell O O 0.9561796188354492
proliferation O O 0.9421035647392273
, O O 0.9893258810043335
peptides O O 0.880882978439331
containing O O 0.9643107056617737
either O O 0.9879187941551208
a O O 0.9884337782859802
single O O 0.9728333950042725
copy O O 0.9251641631126404
of O O 0.9922371506690979
the O O 0.9898125529289246
receptor O O 0.8573579788208008
binding O O 0.9653031826019287
domain O O 0.9218510985374451
or O O 0.9923152923583984
the O O 0.9906678795814514
distal O O 0.834575355052948
heparin B-chemical O 0.7557688355445862
binding O O 0.9639272689819336
domain O O 0.9183045029640198
of O O 0.9892361760139465
apoE B-protein B-protein 0.46246469020843506
did O O 0.9861127734184265
not O O 0.9935018420219421
inhibit O O 0.933348536491394
PDGF-directed - O 0.7422249913215637
smooth O O 0.9636716842651367
muscle O O 0.9500774145126343
cell O O 0.9649257659912109
migration O O 0.9707531332969666
. O O 0.983809232711792

 O O 0.44782784581184387
Growth O O 0.9772377610206604
cones O O 0.9175323247909546
were O O 0.9945297837257385
allowed O O 0.9884019494056702
to O O 0.9926080703735352
internalize O O 0.674231767654419
anti-L1 B-reagent O 0.6191089749336243
Fab I-reagent O 0.5213777422904968
bound O O 0.9503489136695862
to O O 0.9914402961730957
L1 O O 0.6156814098358154
for O O 0.9905637502670288
30 O O 0.9773805737495422
min O O 0.8261284828186035
, O O 0.9919801950454712
and O O 0.9943501353263855
the O O 0.9890333414077759
cell-surface O B-protein 0.4705201983451843
Fab O O 0.5629529356956482
was O O 0.9843196272850037
blocked O O 0.9494830965995789
with O O 0.9892433881759644
unconjugated O B-protein 0.3205675184726715
secondary O O 0.9566143751144409
antibody O O 0.8563812375068665
at O O 0.9900994896888733
4 O O 0.9758188128471375
degrees O O 0.984391450881958
C O O 0.9095523953437805
. O O 0.9832114577293396

After O O 0.9672079682350159
extensive O O 0.9717766046524048
washing O O 0.9299983978271484
, O O 0.9923261404037476
the O O 0.9926326870918274
amount O O 0.9840703010559082
of O O 0.9910455346107483
MyD118/Gadd45 - O 0.7039352059364319
protein O O 0.9326449632644653
bound O O 0.960787832736969
to O O 0.9911205172538757
PCNA B-protein O 0.5117844343185425
was O O 0.985110878944397
assessed O O 0.9679841995239258
using O O 0.9865582585334778
either O O 0.9868974089622498
MyD118- B-reagent O 0.7527404427528381
or O O 0.9885756373405457
Gadd45-specific B-reagent O 0.7081153392791748
antibodies I-reagent O 0.9149064421653748
, O O 0.9913573265075684
which O O 0.9934312701225281
, O O 0.992634117603302
in O O 0.9933178424835205
turn O O 0.9805285334587097
, O O 0.9925405383110046
were O O 0.9941256046295166
reacted O O 0.9409307837486267
with O O 0.9919499158859253
HRP-coupled - O 0.7465734481811523
secondary O O 0.9409465193748474
antibody O O 0.8427926898002625
. O O 0.9816728830337524

While O O 0.9630781412124634
wild-type O O 0.6709847450256348
RDGC B-protein O 0.685510516166687
bound O O 0.9437423944473267
calmodulin B-protein-family O 0.549314022064209
in O O 0.9905920624732971
the O O 0.9921122789382935
presence O O 0.9796333312988281
or O O 0.9929088354110718
absence O O 0.9746165871620178
of O O 0.9913823008537292
Ca2+ B-chemical O 0.7510583996772766
, O O 0.9905693531036377
the O O 0.9918752312660217
interaction O O 0.9725636839866638
between O O 0.9907912015914917
73I12A B-protein O 0.7467319965362549
and O O 0.9899393916130066
calmodulin O O 0.5381865501403809
was O O 0.9854655265808105
strictly O O 0.9760854244232178
Ca2+ O O 0.7693761587142944
dependent O O 0.9741272330284119
( O O 0.9796380400657654
Figure O O 0.9705640077590942
2C) O O 0.753686249256134
. O O 0.9812767505645752

Menin B-protein B-protein 0.08235523104667664
Binds O O 0.6632149815559387
GTP B-chemical O 0.2578209638595581

In O O 0.9782490730285645
a O O 0.9894927740097046
similar O O 0.9890918731689453
fashion O O 0.9608975648880005
, O O 0.9921358823776245
binding O O 0.9747416377067566
of O O 0.9906409382820129
hnRNP B-protein O 0.6757473349571228
A2 I-protein O 0.6640541553497314
to O O 0.9913928508758545
the O O 0.9889195561408997
RTS B-RNA O 0.6042004823684692
might O O 0.9840044975280762
promote O O 0.9736547470092773
unwinding O O 0.8561666011810303
of O O 0.9911621809005737
secondary O O 0.948615312576294
structure O O 0.97718346118927
in O O 0.992462158203125
the O O 0.9902666211128235
mRNA B-RNA O 0.8054119348526001
to O O 0.992271900177002
reduce O O 0.9804361462593079
a O O 0.9864396452903748
kinetic O O 0.8908045291900635
barrier O O 0.9536633491516113
to O O 0.9933660626411438
formation O O 0.9737521409988403
of O O 0.9934367537498474
the O O 0.9919025301933289
translation B-protein-complex O 0.9550051093101501
initiation I-protein-complex O 0.9162653088569641
complex I-protein-complex O 0.9744534492492676
. O O 0.9835086464881897

After O O 0.9593543410301208
transfection O O 0.6077318787574768
of O O 0.990408182144165
vectors O O 0.9311231970787048
expressing O O 0.9590774178504944
MUC1 B-protein O 0.7572248578071594
and O O 0.9911907911300659
GSK3beta B-protein O 0.7486971020698547
, O O 0.9882038831710815
293 O O 0.763071596622467
cells O O 0.977164089679718
were O O 0.9942670464515686
subjected O O 0.9757532477378845
to O O 0.991607666015625
immunoprecipitation O B-protein 0.4696066081523895
with O O 0.9901312589645386
anti-MUC1 B-reagent O 0.7546203136444092
and O O 0.9925071597099304
the O O 0.990426242351532
precipitates O O 0.771805465221405
were O O 0.9925693869590759
analyzed O O 0.9625172019004822
for O O 0.993474543094635
binding O O 0.9762267470359802
of O O 0.9921103119850159
MUC1 O O 0.7579684257507324
to O O 0.9897206425666809
beta-catenin B-protein O 0.5024703145027161
. O O 0.9762740135192871

( O O 0.9289277791976929
Table O O 0.9682746529579163
I O O 0.9867266416549683
, O O 0.9918198585510254
Fig O O 0.8810619115829468
. O O 0.9922417402267456
3 O O 0.9744091033935547
) O O 0.9803076386451721
indicate O O 0.9826176762580872
that O O 0.9952118396759033
the O O 0.9909668564796448
mutant O O 0.8378286957740784
enzymes O O 0.9410597085952759
still O O 0.98665851354599
bind O O 0.9328345656394958
tRNA B-RNA O 0.6677603721618652
efficiently O O 0.9578244090080261
, O O 0.9919913411140442
which O O 0.9935020804405212
argues O O 0.966624915599823
against O O 0.9925962090492249
a O O 0.989959180355072
large O O 0.9886017441749573
structural O O 0.9741698503494263
change O O 0.989615797996521
. O O 0.9843338131904602

The O O 0.9679931402206421
yeast O O 0.8418917655944824
two-hybrid O B-protein 0.3496502637863159
interaction O O 0.9657754898071289
assays O O 0.8991419076919556
indicated O O 0.9763157963752747
that O O 0.9940690994262695
filamin-A B-protein O 0.7686520218849182
does O O 0.9854466915130615
not O O 0.9939747452735901
bind O O 0.9553605318069458
to O O 0.9934813976287842
any O O 0.9885925054550171
integrin B-protein B-protein 0.4735395312309265
β I-protein O 0.61521977186203
subunit O O 0.616156816482544
, O O 0.9889426231384277
whereas O O 0.9658181667327881
filamin-B B-protein O 0.7727664709091187
only O O 0.990372896194458
interacts O O 0.8877561092376709
with O O 0.9919257760047913
β1A B-protein-isoform O 0.7466111183166504
. O O 0.9808095097541809

Plakoglobin B-protein O 0.45914119482040405
binding O O 0.9671106934547424
by O O 0.9939095973968506
human O O 0.9891858100891113
Dsg3 B-protein O 0.730263352394104
( O O 0.9546322822570801
pemphigus B-protein B-protein 0.29025906324386597
vulgaris I-protein O 0.5744190812110901
antigen I-protein O 0.7440851330757141
) O O 0.9771066308021545
in O O 0.9927432537078857
keratinocytes O O 0.8263554573059082
requires O O 0.9821994304656982
the O O 0.9896346926689148
cadherin-like - O 0.6305428743362427
intracytoplasmic O B-protein 0.3514314293861389
segment O O 0.9154723882675171
. O O 0.9810603857040405

We O O 0.976924479007721
interpreted O O 0.9756295084953308
these O O 0.994522213935852
data O O 0.9852191209793091
to O O 0.9942492246627808
reflect O O 0.984990656375885
the O O 0.992043673992157
existence O O 0.9781888127326965
of O O 0.9924433827400208
a O O 0.9845749139785767
ternary O O 0.7081160545349121
protein O O 0.9364306926727295
complex O O 0.9760830402374268
in O O 0.9928810596466064
which O O 0.9916553497314453
MEIS1 B-protein O 0.7206157445907593
binds O O 0.8800403475761414
to O O 0.9927420616149902
a O O 0.9852951765060425
PBX-HOXA9 B-protein-complex O 0.6865679621696472
dimer O O 0.6963669061660767
bound O O 0.9616764783859253
to O O 0.993822455406189
DNA B-DNA O 0.9656183123588562
. O O 0.9836176633834839

( O O 0.9217871427536011
C O O 0.896314263343811
) O O 0.9742274880409241
dFOXO B-protein O 0.7417670488357544
binds O O 0.887810468673706
specifically O O 0.9798780083656311
to O O 0.9931305050849915
d4EBP B-DNA O 0.7676531672477722
and O O 0.991169810295105
dInR B-DNA O 0.7238518595695496
promoters I-DNA O 0.8415502905845642
in O O 0.9910858273506165
vivo O O 0.8547149896621704
. O O 0.9824936985969543

First O O 0.9590975642204285
, O O 0.9907916784286499
gel-shift O O 0.7881481647491455
analysis O O 0.982265830039978
shows O O 0.981700599193573
that O O 0.994145393371582
bacterially O O 0.7470216155052185
expressed O O 0.9705681800842285
Xvent-1 B-protein O 0.6086232662200928
homeodomain O B-protein 0.3052331507205963
binds O O 0.9113122224807739
to O O 0.9928104281425476
the O O 0.9903215765953064
labelled O O 0.8376158475875854
BIE B-DNA O 0.5798282027244568
fragment O O 0.878138542175293
in O O 0.9917625188827515
a O O 0.9872358441352844
concentration-dependent O O 0.7673755884170532
manner O O 0.9839823842048645
, O O 0.9923686385154724
with O O 0.9936726093292236
higher O O 0.9863991737365723
protein O O 0.9438035488128662
concentrations O O 0.9562874436378479
leading O O 0.9789878129959106
to O O 0.9941343665122986
the O O 0.9923581480979919
formation O O 0.9727652668952942
of O O 0.9911223649978638
oligomers O O 0.6780189871788025
( O O 0.9734072685241699
Figure O O 0.967190682888031
4A) O O 0.7442981004714966
. O O 0.980804979801178

B O O 0.6938634514808655
. O O 0.9908677339553833
M O O 0.9240537285804749
. O O 0.9902427792549133
Bradt O B-protein 0.384406179189682
, O O 0.9907256960868835
T O O 0.8474544286727905
. O O 0.9915233850479126
S O O 0.8815035223960876
. O O 0.9904928803443909
Bixby O O 0.6674783825874329
, O O 0.9881225228309631
W O O 0.7739133834838867
. O O 0.991041362285614
P O O 0.8857824802398682
. O O 0.9912891387939453
Kolb O O 0.7580806612968445
and O O 0.9920374155044556
N O O 0.9042449593544006
. O O 0.9916344881057739
R O O 0.8704750537872314
. O O 0.9917478561401367
Cooper O O 0.8839360475540161
, O O 0.9899098873138428
Covalent O O 0.8684625029563904
binding O O 0.9724657535552979
of O O 0.9918791651725769
Alzheimer B-peptide O 0.8977460265159607
' I-peptide O 0.9621058702468872
s I-peptide O 0.8687212467193604
disease I-peptide O 0.980525016784668
A I-peptide O 0.9863268136978149
peptide I-peptide O 0.8012551069259644
with O O 0.9901520609855652
C3 B-protein O 0.7097644805908203
via O O 0.951744019985199
activation O O 0.9299774765968323
of O O 0.992994487285614
both O O 0.9921825528144836
complement O O 0.9449117183685303
pathways O O 0.9482985138893127
. O O 0.9828227162361145

2 O O 0.9112040400505066
) O O 0.9790030121803284
This O O 0.9942670464515686
region O O 0.9861235618591309
is O O 0.9913979768753052
involved O O 0.9869105219841003
in O O 0.9934691190719604
the O O 0.9922447800636292
interaction O O 0.9718591570854187
of O O 0.9912192225456238
C/EBPbeta B-protein O 0.7485269904136658
with O O 0.9914711117744446
other O O 0.9923092126846313
modulating O O 0.766510546207428
proteins O O 0.9545055627822876
bound O O 0.964201033115387
to O O 0.9930838346481323
neighboring O O 0.9635868072509766
cis-regulatory O B-protein 0.42014533281326294
sites O O 0.9732767343521118
, O O 0.9916284084320068
creating O O 0.9763122797012329
structural O O 0.9731703996658325
changes O O 0.9891564846038818
( O O 0.9763447642326355
27) O O 0.7533566355705261
. O O 0.9810656905174255

Deletion O O 0.7197078466415405
analysis O O 0.9811108708381653
confirmed O O 0.9777284264564514
that O O 0.9944788217544556
U2AF65 B-protein O 0.7663118839263916
bound O O 0.9621593952178955
to O O 0.993350088596344
the O O 0.9873782992362976
Py B-DNA B-protein 0.3148365020751953
tract I-DNA O 0.9411042332649231
( O O 0.9769077301025391
data O O 0.9858102202415466
not O O 0.9939152598381042
shown) O O 0.7520977258682251
. O O 0.9807913303375244

 O O 0.45787471532821655
Again O O 0.9798932075500488
, O O 0.9928959012031555
we O O 0.9940695762634277
noted O O 0.9850382208824158
that O O 0.9941186904907227
Ets-1(delta286 B-protein O 0.7436332106590271
) I-protein O 0.9743558764457703
bound O O 0.966416597366333
to O O 0.9937396049499512
both O O 0.9898175597190857
GST B-experiment-tag O 0.5907598733901978
and O O 0.9903220534324646
GST-USF B-experimental-construct O 0.7603068947792053
, O O 0.9911682605743408
which O O 0.9936113953590393
indicated O O 0.9761121273040771
nonspecific O O 0.8295284509658813
interactions O O 0.9736932516098022
. O O 0.9839322566986084

Both O O 0.9681987762451172
GD B-protein O 0.582976222038269
and O O 0.9889919757843018
Snk B-protein O 0.5009754300117493
bind O O 0.9362698197364807
to O O 0.9917382597923279
heparin B-chemical O 0.7791891694068909
- I-chemical O 0.9707322716712952
Sepharose I-chemical O 0.7525290846824646
, O O 0.9904111623764038
providing O O 0.9775443077087402
a O O 0.98895663022995
link O O 0.9601977467536926
between O O 0.9926726222038269
the O O 0.9903664588928223
pipe-defined O O 0.7087545394897461
ventral O O 0.8673063516616821
prepattern O O 0.7487839460372925
and O O 0.9928479194641113
the O O 0.9898819327354431
protease O O 0.6570649743080139
cascade O O 0.830996572971344
. O O 0.9800312519073486

In O O 0.9781333804130554
our O O 0.9892975091934204
efforts O O 0.9857197403907776
to O O 0.9938532114028931
clarify O O 0.9536915421485901
further O O 0.9906867146492004
the O O 0.9920133948326111
roles O O 0.9701429605484009
of O O 0.9894481897354126
Dvl B-protein B-protein 0.3585665225982666
in O O 0.9929845333099365
the O O 0.987006664276123
Wnt B-process B-protein 0.434601366519928
signaling I-process O 0.9167766571044922
pathway I-process O 0.9305927753448486
, O O 0.9912710189819336
we O O 0.9927703738212585
isolated O O 0.9700345993041992
a O O 0.9877327680587769
novel O O 0.9514991641044617
protein O O 0.944856584072113
which O O 0.9919140338897705
binds O O 0.8984449505805969
to O O 0.9930319786071777
the O O 0.9878119826316833
PDZ B-protein-domain B-protein 0.39288586378097534
domain I-protein-domain O 0.9235446453094482
of O O 0.9882639646530151
Dvl O B-protein 0.3737180531024933
by O O 0.9933410286903381
the O O 0.9899339079856873
yeast O O 0.8392783999443054
two-hybrid O B-protein 0.3353976607322693
screening O O 0.9370457530021667
. O O 0.981376588344574

Loss O O 0.9361633658409119
of O O 0.9907855987548828
Fused B-protein O 0.8655246496200562
kinase O O 0.653052031993866
activity O O 0.9799405932426453
or O O 0.9929690957069397
loss O O 0.9822300672531128
of O O 0.9934187531471252
the O O 0.9888922572135925
serine B-protein-region O 0.5966324806213379
931 I-protein-region O 0.5422547459602356
phosphorylation I-protein-region O 0.8581586480140686
site I-protein-region O 0.9626079201698303
could O O 0.9916086792945862
reduce O O 0.9770948886871338
Ci B-protein O 0.6402603983879089
binding O O 0.9662820100784302
to O O 0.9917500615119934
Cos2 B-protein O 0.7494874000549316
, O O 0.9900996088981628
which O O 0.9930393099784851
could O O 0.9926217794418335
, O O 0.9924667477607727
in O O 0.9931257963180542
turn O O 0.9793537855148315
, O O 0.9912761449813843
reduce O O 0.9761931300163269
Ci O O 0.6369978785514832
processing O O 0.9706454277038574
by O O 0.9929671287536621
preventing O O 0.9697433710098267
the O O 0.9913375377655029
processing O O 0.9718688130378723
enzyme O O 0.9030817151069641
from O O 0.9904838800430298
interacting O O 0.9394105076789856
with O O 0.991457998752594
Ci O O 0.6345852613449097
. O O 0.9797855019569397

35S-labeled B-experiment-tag O 0.3751033842563629
Arr2 B-protein O 0.6415093541145325
bound O O 0.9574679136276245
to O O 0.9921562671661377
PIP3 B-reagent O 0.7276736497879028
beads I-reagent O 0.8805551528930664
but O O 0.9935979843139648
not O O 0.9949643611907959
to O O 0.994373083114624
control B-reagent O 0.9809494614601135
beads I-reagent O 0.8888457417488098
( O O 0.9768053293228149
Figure O O 0.968305766582489
2D) O O 0.7459931969642639
. O O 0.9808484315872192

Fractionation O O 0.4641057848930359
of O O 0.9878985285758972
splicing O O 0.8537259697914124
extracts O O 0.9421743750572205
showed O O 0.982631504535675
that O O 0.9954795837402344
two O O 0.9924577474594116
fractions O O 0.9068880081176758
associated O O 0.9843122363090515
with O O 0.9907916784286499
U2 B-RNA O 0.6412128806114197
snRNP I-RNA B-protein 0.2692108154296875
, O O 0.9918555021286011
SF3a B-protein-complex O 0.7408388257026672
and O O 0.9908672571182251
SF3b B-protein-complex O 0.7623919248580933
, O O 0.9909249544143677
are O O 0.9949883818626404
required O O 0.9903441071510315
for O O 0.9940244555473328
the O O 0.992534875869751
binding O O 0.9734708666801453
of O O 0.9896348118782043
U2 O O 0.6173169016838074
snRNP O B-protein 0.2634340822696686
to O O 0.9932817220687866
pre-mRNAs B-RNA O 0.7292037606239319
( O O 0.9754245281219482
10 O O 0.9852110147476196
, O O 0.9919193983078003
31) O O 0.7587673664093018
. O O 0.9813278317451477

These O O 0.9812970757484436
data O O 0.9841288328170776
indicate O O 0.981951892375946
that O O 0.9941264390945435
Sir4 B-protein O 0.7568029761314392
binding O O 0.9690019488334656
to O O 0.991703987121582
Rap1 B-protein O 0.7140094041824341
initiates O O 0.8521014451980591
the O O 0.9897438883781433
sequential O O 0.9024389982223511
association O O 0.9666517972946167
of O O 0.9923110008239746
Sir B-protein-family O 0.9242259860038757
and O O 0.9931250810623169
other O O 0.9934095144271851
proteins O O 0.9630894064903259
, O O 0.9920192360877991
allowing O O 0.9828739762306213
the O O 0.9918937087059021
subsequent O O 0.9719278216362
spreading O O 0.959551990032196
of O O 0.9924966096878052
the O O 0.9886491298675537
heterochromatin O O 0.5370386242866516
proteins O O 0.9529742002487183
along O O 0.9830138683319092
the O O 0.991666853427887
chromosome O O 0.9081199169158936
. O O 0.9822194576263428

PU B-protein O 0.37737730145454407
. I-protein O 0.9883407354354858
1 I-protein O 0.9764789938926697
binds O O 0.9087633490562439
to O O 0.9935520887374878
the O O 0.9892532229423523
CH3 B-protein-domain O 0.5737509727478027
domain I-protein-domain O 0.9039610028266907
of O O 0.9895541667938232
CBP B-protein O 0.620931088924408
( O O 0.9691651463508606
82 O O 0.9107533693313599
) O O 0.9790666699409485
( O O 0.9792434573173523
Fig O O 0.8969079852104187
. O O 0.9922019243240356
5D) O O 0.7563084959983826
. O O 0.9813451766967773

